<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>060 Pharmacology Neet 2024 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}


    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / PYQs / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">24</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x2a1f1a=_0x3fb3;(function(_0x10579b,_0x16bcff){const _0x376b4b=_0x3fb3,_0x3f047f=_0x10579b();while(!![]){try{const _0x2c3019=-parseInt(_0x376b4b(0x1ca))/0x1+parseInt(_0x376b4b(0x261))/0x2*(parseInt(_0x376b4b(0x1cc))/0x3)+-parseInt(_0x376b4b(0x1ea))/0x4*(-parseInt(_0x376b4b(0x1fb))/0x5)+parseInt(_0x376b4b(0x18d))/0x6+parseInt(_0x376b4b(0x277))/0x7*(parseInt(_0x376b4b(0xcf))/0x8)+-parseInt(_0x376b4b(0x191))/0x9+-parseInt(_0x376b4b(0x120))/0xa*(parseInt(_0x376b4b(0x283))/0xb);if(_0x2c3019===_0x16bcff)break;else _0x3f047f['push'](_0x3f047f['shift']());}catch(_0x451e45){_0x3f047f['push'](_0x3f047f['shift']());}}}(_0x14a2,0x5e0e1));const _0x4ba338=(function(){const _0x3aed7f=_0x3fb3,_0x78fd63={'oAXxL':function(_0x21b5fc,_0x436912){return _0x21b5fc===_0x436912;},'XCqkq':_0x3aed7f(0xc7),'HHKco':_0x3aed7f(0xe8),'xUcLm':function(_0x371862,_0xc5e2e6){return _0x371862>_0xc5e2e6;},'PgCVz':function(_0x1b4f9c,_0x5553de){return _0x1b4f9c+_0x5553de;},'KDdmq':function(_0x4033e8,_0x2252fc){return _0x4033e8/_0x2252fc;},'IUWUF':function(_0x59566b,_0x587d70){return _0x59566b%_0x587d70;},'xattb':'timeSpent','lPcQh':function(_0x336709,_0x2def20){return _0x336709+_0x2def20;},'uoYAr':function(_0x49654b,_0x468deb){return _0x49654b!==_0x468deb;},'lcWhF':_0x3aed7f(0x206),'jKIbj':_0x3aed7f(0x11b)};let _0x2d4095=!![];return function(_0x4bf3d5,_0x2a20b8){const _0x58a38d=_0x3aed7f,_0x5da7f3={'xOmLU':function(_0x23fc8c,_0x30b066){return _0x78fd63['oAXxL'](_0x23fc8c,_0x30b066);},'nRVnS':_0x78fd63[_0x58a38d(0xae)],'iqKMB':function(_0x2434cd,_0x3f4854){return _0x2434cd===_0x3f4854;},'Hinol':_0x78fd63[_0x58a38d(0x1ab)],'CZrPu':_0x58a38d(0xd3),'XMmsC':function(_0x11d28f,_0x3ee14c){const _0x4fd9c4=_0x58a38d;return _0x78fd63[_0x4fd9c4(0x2ab)](_0x11d28f,_0x3ee14c);},'CSGKM':_0x58a38d(0x292),'XzmWT':function(_0x445e59,_0x4b42f3){return _0x78fd63['PgCVz'](_0x445e59,_0x4b42f3);},'yhKxX':function(_0x165bb5,_0x1b118f){const _0x5325f8=_0x58a38d;return _0x78fd63[_0x5325f8(0x2a3)](_0x165bb5,_0x1b118f);},'sIoEd':function(_0x2cf04e,_0x429847){const _0x10b330=_0x58a38d;return _0x78fd63[_0x10b330(0x1e0)](_0x2cf04e,_0x429847);},'kqlvA':_0x78fd63[_0x58a38d(0xa3)],'GyJJq':function(_0x40c0a0,_0x237eb2){const _0x32f936=_0x58a38d;return _0x78fd63[_0x32f936(0x2bf)](_0x40c0a0,_0x237eb2);}};if(_0x78fd63['uoYAr'](_0x78fd63[_0x58a38d(0x1db)],_0x78fd63[_0x58a38d(0x1dd)])){const _0x45c4c9=_0x2d4095?function(){const _0x17a7fe=_0x58a38d;if(_0x2a20b8){const _0x54059e=_0x2a20b8[_0x17a7fe(0x223)](_0x4bf3d5,arguments);return _0x2a20b8=null,_0x54059e;}}:function(){};return _0x2d4095=![],_0x45c4c9;}else{if(_0x5da7f3['xOmLU'](_0x15b6a9,_0x5da7f3[_0x58a38d(0x1d7)])||_0x5da7f3[_0x58a38d(0x2bc)](_0x2b9288,_0x5da7f3['Hinol'])){_0x1551e2[_0x58a38d(0x284)](_0x58a38d(0x10a))[_0x58a38d(0x113)]=_0x21d31a[_0x58a38d(0x10c)],_0x5a5da7[_0x58a38d(0x284)]('incorrectCount')[_0x58a38d(0x113)]=_0x136413['incorrectAnswers'],_0x537283['getElementById'](_0x5da7f3[_0x58a38d(0x1e1)])[_0x58a38d(0x113)]=_0x507093[_0x58a38d(0xd3)];const _0x3ce4a3=_0x5da7f3[_0x58a38d(0xe5)](_0x14d9f1['totalAttempted'],0x0)?_0x2bf12a[_0x58a38d(0x132)](_0x4272ff[_0x58a38d(0x10c)]/_0x43e18a[_0x58a38d(0xd3)]*0x64):0x0;_0x2e24b9[_0x58a38d(0x284)](_0x5da7f3[_0x58a38d(0x2d7)])[_0x58a38d(0x113)]=_0x5da7f3[_0x58a38d(0x316)](_0x3ce4a3,'%'),_0x743346[_0x58a38d(0xad)]=_0x545496[_0x58a38d(0x279)]((_0x53fe00,_0x430eeb)=>_0x53fe00+_0x430eeb[_0x58a38d(0x1d8)],0x0);const _0x29631c=_0x55972e[_0x58a38d(0x138)](_0x5da7f3['yhKxX'](_0x1f4ac1[_0x58a38d(0xad)],0x3e8)),_0x517650=_0x514461[_0x58a38d(0x138)](_0x5da7f3[_0x58a38d(0xd5)](_0x29631c,0x3c)),_0x26e248=_0x5da7f3[_0x58a38d(0x156)](_0x29631c,0x3c);_0x5546e1[_0x58a38d(0x284)](_0x5da7f3[_0x58a38d(0x2ac)])[_0x58a38d(0x113)]=_0x5da7f3[_0x58a38d(0x20c)](_0x5da7f3[_0x58a38d(0x316)](_0x517650,':'),_0x26e248[_0x58a38d(0x2f6)]()[_0x58a38d(0x164)](0x2,'0'));}}};}()),_0xba3c2b=_0x4ba338(this,function(){const _0x15bb48=_0x3fb3,_0x2dfe3a={'ffOca':_0x15bb48(0x296)};return _0xba3c2b[_0x15bb48(0x2f6)]()[_0x15bb48(0x305)](_0x15bb48(0x296))['toString']()[_0x15bb48(0x137)](_0xba3c2b)['search'](_0x2dfe3a['ffOca']);});_0xba3c2b();const _0x995a6=(function(){const _0x58267f=_0x3fb3,_0x424ef7={'aIaUK':function(_0x397f45,_0x50fb1f){return _0x397f45===_0x50fb1f;},'mNjpq':_0x58267f(0x306)};let _0x355800=!![];return function(_0x27a78b,_0x3105c2){const _0x473c34={'yxNPs':function(_0x431a63,_0xd3e684){const _0x52bf0d=_0x3fb3;return _0x424ef7[_0x52bf0d(0x1a0)](_0x431a63,_0xd3e684);},'QAvhG':_0x424ef7['mNjpq']},_0x41725e=_0x355800?function(){const _0xb30652=_0x3fb3;if(_0x473c34[_0xb30652(0x16d)](_0x473c34[_0xb30652(0x319)],_0x473c34[_0xb30652(0x319)])){if(_0x3105c2){const _0x413128=_0x3105c2[_0xb30652(0x223)](_0x27a78b,arguments);return _0x3105c2=null,_0x413128;}}else _0x1e2b42[_0xb30652(0x320)]=_0x46467d;}:function(){};return _0x355800=![],_0x41725e;};}()),_0x31859a=_0x995a6(this,function(){const _0x4226e7=_0x3fb3,_0x547bda={'nWAWs':function(_0xe5532c,_0x186f6b){return _0xe5532c(_0x186f6b);},'ybiCr':function(_0x408d4c,_0x384e0a){return _0x408d4c+_0x384e0a;},'JcKfF':_0x4226e7(0x1b4),'DwkeP':function(_0x12ad0a){return _0x12ad0a();},'Ywteb':'log','UZnQx':_0x4226e7(0x209),'HttMA':_0x4226e7(0x18a),'hLdgf':_0x4226e7(0x2d4),'zKHUT':_0x4226e7(0x311),'wDrMu':_0x4226e7(0x211),'PKyDE':'trace','mXeaK':function(_0x173944,_0x298cfa){return _0x173944<_0x298cfa;},'UfEaI':function(_0x2dc40b,_0x403ca1){return _0x2dc40b===_0x403ca1;},'AJQKw':_0x4226e7(0xd1),'HGDIL':'fNewU'};let _0x5238b1;try{const _0x5deaab=_0x547bda[_0x4226e7(0xac)](Function,_0x547bda['ybiCr'](_0x547bda[_0x4226e7(0x285)](_0x547bda[_0x4226e7(0x201)],_0x4226e7(0x28f)),');'));_0x5238b1=_0x547bda[_0x4226e7(0x1b6)](_0x5deaab);}catch(_0x16bccf){_0x5238b1=window;}const _0x1be740=_0x5238b1[_0x4226e7(0x24d)]=_0x5238b1['console']||{},_0x39337f=[_0x547bda['Ywteb'],_0x547bda[_0x4226e7(0xc2)],_0x547bda[_0x4226e7(0xef)],_0x547bda[_0x4226e7(0x10f)],_0x547bda[_0x4226e7(0xb6)],_0x547bda['wDrMu'],_0x547bda[_0x4226e7(0xb5)]];for(let _0x381379=0x0;_0x547bda[_0x4226e7(0x322)](_0x381379,_0x39337f[_0x4226e7(0x17f)]);_0x381379++){if(_0x547bda['UfEaI'](_0x547bda[_0x4226e7(0x1aa)],_0x547bda[_0x4226e7(0x1d4)])){if(_0x425035)_0xb92a2[_0x4226e7(0x262)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x27e836+_0x4226e7(0x106);}else{const _0x36a7e2=_0x995a6[_0x4226e7(0x137)][_0x4226e7(0x2f4)][_0x4226e7(0x1f4)](_0x995a6),_0x29e714=_0x39337f[_0x381379],_0x204d5e=_0x1be740[_0x29e714]||_0x36a7e2;_0x36a7e2[_0x4226e7(0x128)]=_0x995a6[_0x4226e7(0x1f4)](_0x995a6),_0x36a7e2[_0x4226e7(0x2f6)]=_0x204d5e[_0x4226e7(0x2f6)][_0x4226e7(0x1f4)](_0x204d5e),_0x1be740[_0x29e714]=_0x36a7e2;}}});function _0x3fb3(_0x3c2fb6,_0x5959f9){const _0x189c15=_0x14a2();return _0x3fb3=function(_0x31859a,_0x995a6){_0x31859a=_0x31859a-0x98;let _0x455096=_0x189c15[_0x31859a];return _0x455096;},_0x3fb3(_0x3c2fb6,_0x5959f9);}_0x31859a();let questionsData=[{'text':'A\x20man\x20presents\x20with\x20mixed\x20infection\x20of\x20Plasmodium\x20vivax\x20and\x20Plasmodium\x20falciparum\x20in\x20a\x20health\x20centre\x20in\x20Rajasthan.\x20What\x20is\x20the\x20dosage\x20of\x20the\x20treatment\x20given\x20on\x20the\x20second\x20day?','choices':[{'id':0x1,'text':'4\x20tablets\x20of\x20Artesunate\x2050mg\x20+\x206\x20tablets\x20of\x20Primaquine\x202.5mg'},{'id':0x2,'text':_0x2a1f1a(0x257)},{'id':0x3,'text':_0x2a1f1a(0x264)},{'id':0x4,'text':_0x2a1f1a(0x267)}],'correct_choice_id':0x1,'solution':'<p>The\x20dosage\x20of\x20the\x20treatment\x20given\x20on\x20the\x20<strong>second\x20day</strong>\x20for\x20<strong>mixed\x20infection</strong>\x20with\x20<em><strong>Plasmodium\x20vivax\x20</strong></em>and<em><strong>\x20Plasmodium\x20falciparum\x20</strong></em>is\x20<strong>4\x20tablets\x20of\x20Artesunate\x2050mg\x20+\x206\x20tablets\x20of\x20Primaquine\x202.5mg.</strong></p>\x0a<p>For\x20treating\x20mixed\x20infections\x20of\x20<strong><em>Plasmodium\x20vivax</em></strong>\x20and\x20<em><strong>Plasmodium\x20falciparum</strong></em>,\x20the\x20following\x20treatment\x20regimen\x20is\x20recommended.\u00a0This\x20approach\x20ensures\x20comprehensive\x20treatment\x20by\x20addressing\x20both\x20the\x20<strong>blood\x20stages</strong>\x20of\x20<strong><em>Plasmodium\x20falciparum</em>\x20</strong>with\x20<strong>ACT</strong>\x20and\x20the\x20<strong>liver\x20stages</strong>\x20of\x20<strong><em>Plasmodium\x20vivax</em></strong>\x20with\x20<strong>Primaquine</strong>.</p>','explanation_video':'','question_images':[],'explanation_images':[_0x2a1f1a(0x17c)]},{'text':_0x2a1f1a(0x2f3),'choices':[{'id':0x1,'text':'Bortezomib'},{'id':0x2,'text':'Lenalidomide'},{'id':0x3,'text':_0x2a1f1a(0x251)},{'id':0x4,'text':'Elotuzumab'}],'correct_choice_id':0x1,'solution':_0x2a1f1a(0x249),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20presented\x20with\x20breathing\x20difficulty\x20and\x20nasal\x20polyposis\x20when\x20he\x20took\x20aspirin\x20for\x20fever.\x20He\x20faced\x20this\x20issue\x20previously\x20too\x20when\x20he\x20took\x20aspirin.\x20Which\x20among\x20the\x20following\x20is\x20not\x20true\x20about\x20this?','choices':[{'id':0x1,'text':_0x2a1f1a(0x1ae)},{'id':0x2,'text':_0x2a1f1a(0x1ac)},{'id':0x3,'text':'Occur\x20on\x20exposure\x20to\x20only\x20aspirin'},{'id':0x4,'text':_0x2a1f1a(0x27a)}],'correct_choice_id':0x3,'solution':_0x2a1f1a(0x2bd),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x24a),'choices':[{'id':0x1,'text':_0x2a1f1a(0x295)},{'id':0x2,'text':_0x2a1f1a(0x144)},{'id':0x3,'text':_0x2a1f1a(0x18c)},{'id':0x4,'text':'Telenzipine'}],'correct_choice_id':0x3,'solution':_0x2a1f1a(0x27c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x22d),'choices':[{'id':0x1,'text':_0x2a1f1a(0x183)},{'id':0x2,'text':_0x2a1f1a(0x227)},{'id':0x3,'text':_0x2a1f1a(0x127)},{'id':0x4,'text':_0x2a1f1a(0x259)}],'correct_choice_id':0x3,'solution':_0x2a1f1a(0x189),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Lignocaine\x20is\x20used\x20in\x20a\x20loading\x20dose\x20for\x20the\x20treatment\x20of\x20arrhythmias.\x20The\x20loading\x20dose\x20of\x20this\x20drug\x20depends\x20upon\x20which\x20of\x20the\x20following\x20factors?','choices':[{'id':0x1,'text':_0x2a1f1a(0x2c7)},{'id':0x2,'text':_0x2a1f1a(0x29a)},{'id':0x3,'text':_0x2a1f1a(0x301)},{'id':0x4,'text':'Bioavailability'}],'correct_choice_id':0x2,'solution':_0x2a1f1a(0x109),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0xff),'choices':[{'id':0x1,'text':'Furosemide'},{'id':0x2,'text':_0x2a1f1a(0x2c3)},{'id':0x3,'text':_0x2a1f1a(0x2a6)},{'id':0x4,'text':_0x2a1f1a(0xc3)}],'correct_choice_id':0x3,'solution':'<p>For\x20a\x20<strong>hypertensive</strong>\x20patient\x20with\x20<strong>chronic\x20kidney\x20disease</strong>\x20experiencing\x20frequent\x20attacks\x20of\x20<strong>renal\x20colic</strong>,\x20<strong>hydrochlorothiazide</strong>,\x20a\x20<strong>thiazide\x20diuretic</strong>,\x20is\x20often\x20used.</p>\x0a<p><strong>Thiazide\x20diuretics</strong>\x20are\x20particularly\x20effective\x20in\x20cases\x20of\x20<strong>calcium\x20oxalate\x20kidney\x20stones</strong>\x20because\x20they\x20<strong>reduce\x20urinary\x20calcium\x20excretion</strong>.\x20They\x20work\x20by\x20acting\x20on\x20the\x20<strong>distal\x20convoluted\x20tubule\x20(DCT)</strong>\x20of\x20the\x20nephron,\x20where\x20they<strong>\x20inhibit</strong>\x20the\x20<strong>Na+/Cl-\x20co-transporter</strong>.\x20This\x20<strong>inhibition\x20decreases</strong>\x20the\x20<strong>intracellular\x20sodium\x20concentration</strong>,\x20which,\x20through\x20compensatory\x20mechanisms,\x20leads\x20to<strong>\x20increased\x20calcium\x20reabsorption</strong>\x20into\x20the\x20bloodstream.</p>\x0a<p>While\x20this\x20mechanism\x20helps\x20in\x20<strong>decreasing\x20urinary\x20calcium</strong>\x20and\x20<strong>managing\x20calcium\x20oxalate\x20stones</strong>,\x20thiazide\x20diuretics\x20can\x20also\x20cause\x20<strong>adverse\x20effects</strong>\x20such\x20as\x20<strong>hypokalemia</strong>,\x20<strong>hyperuricemia</strong>,\x20and\x20<strong>hypercalcemia</strong>.\x20The\x20<strong>increased\x20reabsorption</strong>\x20of\x20<strong>uric\x20acid</strong>\x20due\x20to\x20the\x20diuretic\x20effect\x20can\x20exacerbate\x20conditions\x20like\x20<strong>gout</strong>\x20and\x20should\x20be\x20monitored\x20carefully.</p>\x0a<p>In\x20addition\x20to\x20their\x20use\x20in\x20treating\x20calcium\x20oxalate\x20kidney\x20stones,\x20thiazide\x20diuretics\x20are\x20commonly\x20prescribed\x20for\x20managing\x20<strong>uncomplicated\x20hypertension</strong>\x20and\x20treating\x20<strong>edema</strong>\x20associated\x20with\x20<strong>heart,\x20liver</strong>,\x20and\x20<strong>kidney</strong>\x20diseases.\x20They\x20are\x20also\x20used\x20for\x20conditions\x20like\x20<strong>osteoporosis</strong>\x20and\x20<strong>nephrogenic\x20diabetes\x20insipidus</strong>.\u00a0</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Furosemide</strong>\x20is\x20a\x20<strong>diuretic</strong>\x20that\x20can\x20<strong>increase\x20calcium\x20excretion</strong>,\x20potentially\x20<strong>raising\x20PTH\x20</strong>as\x20the\x20body\x20tries\x20to\x20conserve\x20calcium.</p>\x0a<p>Option\x20B:\x20<strong>Osmotic\x20diuretics</strong>,\x20like\x20<strong>mannitol</strong>,<strong>\x20retain\x20water</strong>\x20isoosmotically\x20in\x20the\x20<strong>proximal\x20convoluted\x20tubule\x20(PCT)</strong>\x20and\x20<strong>descending\x20loop\x20of\x20Henle</strong>\x20which\x20are\x20freely\x20permeable\x20to\x20water.\x20Luminal\x20fluid\x20is\x20diluted\x20and\x20opposes\x20NaCl\x20reabsorption\x20and\x20promotes\x20calcium\x20excretion.\x20They\x20are\x20indicated\x20in\x20<strong>raised\x20intracranial\x20tension</strong>\x20and\x20in\x20<strong>dialysis\x20disequilibrium</strong>.</p>\x0a<p>Option\x20D:\x20<strong>Spironolactone</strong>\x20is\x20a\x20<strong>potassium-sparing\x20diuretic</strong>\x20and\x20<strong>aldosterone\x20antagonist</strong>.\x20It\x20works\x20by\x20<strong>competitively\x20inhibiting\x20aldosterone\x20receptors</strong>\x20in\x20the\x20distal\x20tubules\x20of\x20the\x20kidney.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x170),'choices':[{'id':0x1,'text':_0x2a1f1a(0x252)},{'id':0x2,'text':'Amino\x20caproic\x20acid'},{'id':0x3,'text':_0x2a1f1a(0x14f)},{'id':0x4,'text':_0x2a1f1a(0x318)}],'correct_choice_id':0x2,'solution':_0x2a1f1a(0x146),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/027728f8da6746d1b3504b71d1062798.JPEG'],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/eaf426b95b65411ab20b432201766924x1280x1403.JPEG']},{'text':'Which\x20of\x20the\x20following\x20beta-adrenergic\x20blockers\x20are\x20beneficial\x20for\x20patients\x20with\x20reduced\x20ejection\x20fraction\x20and\x20can\x20reduce\x20mortality\x20in\x20chronic\x20heart\x20failure\x20without\x20causing\x20exacerbations\x20over\x20a\x20few\x20years?','choices':[{'id':0x1,'text':_0x2a1f1a(0x121)},{'id':0x2,'text':'Pindolol'},{'id':0x3,'text':'Esmolol'},{'id':0x4,'text':_0x2a1f1a(0x11c)}],'correct_choice_id':0x4,'solution':'<p>The\x20<strong>beta-adrenergic\x20blocker</strong>\x20that\x20is\x20useful\x20in\x20patients\x20with\x20<strong>reduced\x20ejection\x20fraction\x20a</strong>nd\x20can<strong>\x20reduce\x20mortality\x20</strong>in\x20<strong>chronic\x20heart\x20failure\x20</strong>without\x20causing\x20exacerbations\x20over\x20a\x20few\x20years\x20is\x20<strong>bisoprolol.</strong></p>\x0a<p><strong>Bisoprolol</strong>\x20is\x20preferred\x20for\x20use\x20in\x20patients\x20having\x20<strong>heart\x20failure\x20with\x20reduced\x20ejection\x20fraction\x20(HFrEF)</strong>.</p>\x0a<p>The\x20<strong>exacerbation</strong>\x20mentioned\x20in\x20the\x20context\x20of\x20<strong>beta-blockers</strong>\x20for\x20heart\x20failure\x20refers\x20to\x20the\x20potential\x20<strong>worsening</strong>\x20of\x20<strong>heart\x20failure\x20symptoms</strong>\x20in\x20some\x20patients,\x20despite\x20the\x20overall\x20benefits\x20of\x20these\x20medications.\x20They\x20can\x20sometimes\x20lead\x20to\x20a<strong>\x20decline</strong>\x20in\x20<strong>left\x20ventricular\x20function</strong>,\x20particularly\x20in\x20individuals\x20with\x20<strong>limited\x20cardiac\x20reserve</strong>\x20who\x20rely\x20heavily\x20on\x20<strong>adrenergic\x20stimulation</strong>.\x20This\x20deterioration\x20can\x20manifest\x20as\x20<strong>increased\x20heart\x20failure\x20symptoms</strong>\x20or\x20a\x20<strong>decrease</strong>\x20in\x20<strong>cardiac\x20function</strong>.\x20The\x20<strong>only\x20beta-blockers</strong>\x20that\x20have\x20been\x20proven\x20to<strong>\x20improve</strong>\x20the\x20<strong>survival</strong>\x20of\x20patients\x20with\x20<strong>HFrEF</strong>\x20or\x20<strong>chronic\x20HF</strong>\x20are\x20-</p>\x0a<ul>\x0a<li><strong>B</strong>isoprolol</li>\x0a<li><strong>M</strong>etoprolol</li>\x0a<li><strong>C</strong>arvedilol</li>\x0a</ul>\x0a<p><strong>HFrEF</strong>\x20is\x20a\x20complex\x20clinical\x20syndrome\x20where\x20the\x20ventricle\x20fails\x20to\x20adequately\x20fill\x20with\x20or\x20eject\x20blood,\x20typically\x20defined\x20by\x20an\x20<strong>ejection\x20fraction\x20(EF)\x20less\x20than\x20or\x20equal\x20to\x2040%</strong>.\x20Key\x20etiologies\x20include\x20<strong>coronary\x20artery\x20disease,\x20valvular\x20heart\x20disease,\x20congenital\x20heart\x20diseases,\x20and\x20autoimmune\x20diseases\x20like\x20giant\x20cell\x20myocarditis</strong>.\x20Patients\x20with\x20HFrEF\x20commonly\x20experience\x20symptoms\x20like\x20<strong>dyspnea\x20on\x20exertion</strong>,\x20orthopnea,\x20and\x20paroxysmal\x20nocturnal\x20dyspnea,\x20and\x20may\x20present\x20with\x20<strong>pedal\x20edema</strong>,\x20elevated\x20jugular\x20venous\x20pressure\x20(JVP),\x20ascites,\x20and\x20hepatomegaly\x20on\x20examination.</p>\x0a<p>The\x20pharmacological\x20<strong>management</strong>\x20of\x20HFrEF\x20involves\x20drugs\x20with\x20both\x20<strong>symptomatic</strong>\x20and\x20<strong>mortality\x20benefits</strong>,\x20including\x20<strong>Angiotensin\x20receptor–neprilysin\x20inhibitors\x20(ARNIs)</strong>\x20such\x20as\x20sacubitril/valsartan,\x20angiotensin-converting\x20enzyme\x20<strong>(ACE)\x20inhibitors</strong>\x20like\x20ramipril\x20and\x20enalapril,\x20β-blockers\x20such\x20as\x20metoprolol\x20and\x20carvedilol,\x20mineralocorticoid\x20receptor\x20antagonists\x20like\x20spironolactone\x20and\x20eplerenone,<strong>\x20sodium-glucose\x20cotransporter\x202\x20(SGLT2)\x20inhibitors\x20</strong>like\x20dapagliflozin,\x20and\x20hydralazine\x20plus\x20isosorbide\x20dinitrate\x20(noting\x20a\x20mortality\x20benefit\x20specifically\x20in\x20African-American\x20patients).\x20Drugs\x20used\x20primarily\x20for<strong>\x20symptomatic\x20relief</strong>,\x20such\x20as\x20<strong>loop\x20diuretics</strong>\x20(e.g.,\x20furosemide),\x20and\x20digoxin,\x20are\x20reserved\x20for\x20specific\x20indications\x20or\x20during\x20decompensation.\x20<strong>Non-pharmacological\x20</strong>therapies\x20for\x20HFrEF\x20include\x20<strong>implantable\x20cardioverter-defibrillators\x20(ICD)\x20</strong>and\x20<strong>cardiac\x20resynchronization\x20therapy.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x2b2),'choices':[{'id':0x1,'text':_0x2a1f1a(0x269)},{'id':0x2,'text':_0x2a1f1a(0x26c)},{'id':0x3,'text':_0x2a1f1a(0x2d5)},{'id':0x4,'text':_0x2a1f1a(0x149)}],'correct_choice_id':0x1,'solution':_0x2a1f1a(0x32a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20who\x20recently\x20underwent\x20surgery\x20has\x20complaints\x20of\x20nausea\x20and\x20vomiting.\x20He\x20was\x20prescribed\x20a\x20drug\x20called\x20aprepitant.\x20What\x20is\x20its\x20mechanism\x20of\x20action?','choices':[{'id':0x1,'text':'NK-3\x20antagonist'},{'id':0x2,'text':_0x2a1f1a(0x23e)},{'id':0x3,'text':'NK-1\x20antagonist'},{'id':0x4,'text':'NK-1\x20agonist'}],'correct_choice_id':0x3,'solution':'<p>PONV\x20Physiology:\x20<span\x20style=\x22font-family:\x20arial,\x20helvetica,\x20sans-serif;\x20font-size:\x2012pt;\x22><strong>Afferents</strong>\x20from\x20the\x20<strong>chemoreceptor\x20trigger\x20zone\x20</strong>(CTZ),\x20<strong>vagal\x20neurons</strong>\x20in\x20the\x20gastrointestinal\x20system,\x20neurons\x20from\x20the\x20vestibular\x20system\x20and\x20midbrain\x20afferents\x20<strong>relay</strong>\x20within\x20the\x20<strong>vomiting\x20centre</strong>\x20in\x20the\x20reticular\x20formation\x20of\x20the\x20brainstem\x20which\x20then\x20project\x20into\x20the\x20<strong>nucleus\x20tractus\x20solitarius</strong>.</span></p>\x0a<p><strong>Risk\x20factors</strong>\x20for\x20PONV\x20are\x20divided\x20into:</p>\x0a<ul>\x0a<li>Patient\x20factors\x0a<ul>\x0a<li><strong>Female</strong>&gt;male</li>\x0a<li>Age<strong>&lt;50\x20years</strong></li>\x0a<li>Prior\x20history\x20of\x20<strong>motion\x20sickness</strong></li>\x0a<li><strong>Non-smokers</strong>\x20&gt;\x20smokers\x20(<strong>CTZ</strong>\x20is\x20<strong>desensitized</strong>)</li>\x0a</ul>\x0a</li>\x0a<li>Preoperative\x20factors\x0a<ul>\x0a<li>(<strong>Fasting\x20</strong>and\x20<strong>anxiety</strong>,\x20while\x20possibly\x20contributing\x20to\x20PONV,\x20have\x20yet\x20to\x20be\x20demonstrated)</li>\x0a</ul>\x0a</li>\x0a<li>Intraoperative\x20factors\x0a<ul>\x0a<li>Surgical\x20-\x20<strong>Cholecystectomy,\x20gynaecological</strong>\x20and\x20<strong>laparoscopic</strong>\x20procedures\x20have\x20higher\x20incidences</li>\x0a<li>Drugs\x20-\x20<strong>Nitrous\x20oxide</strong>,\x20<strong>Opioids</strong>,\x20Cyclopropane,</li>\x0a<li><strong>General\x20anaesthesia</strong>\x20has\x20a\x20times\x20<strong>more\x20risk</strong>\x20of\x20developing\x20PONV\x20than\x20regional\x20anaesthesia.</li>\x0a</ul>\x0a</li>\x0a<li>Postoperative\x20factors\x0a<ul>\x0a<li><strong>Pain</strong>\x20and\x20<strong>early\x20ambulatio</strong>n\x20contribute\x20to\x20a\x20higher\x20risk\x20of\x20PONV.</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Scoring\x20systems\x20</strong>used\x20to\x20grade\x20PONV\x20are<strong>\x20</strong>the<strong>\x20Apfel\x20score\x20</strong>and\x20the<strong>\x20Koivuranta\x20score.</strong></p>\x0a<p>Drugs\x20used\x20in\x20the\x20<strong>prophylaxis</strong>\x20and\x20treatment\x20of\x20PONV:</p>\x0a<ul>\x0a<li>5-HT\x203\x20antagonists\x20-\x20<strong>ondansetron</strong>,\x20palonosetron</li>\x0a<li>Butyrophenones-\x20<strong>droperidol</strong></li>\x0a<li><strong>Dexamethasone</strong></li>\x0a<li>Transdermal\x20scopolamine</li>\x0a<li><strong>Aprepitant</strong></li>\x0a</ul>\x0a<p>Note:<strong>\x20Double-blind\x20studies</strong>\x20have\x20found\x20<strong>no\x20difference</strong>\x20in\x20the\x20efficacy\x20between\x20<strong>aprepitant(NK1\x20antagonists)</strong>\x20and\x20<strong>ondansetron\x20(5HT3\x20antagonist)</strong>\x20in\x20the\x20<strong>first\x2024\x20hours</strong>\x20following\x20surgery.\x20But\x20<strong>after\x2024\x20hours</strong>\x20<strong>aprepitant</strong>\x20has\x20proven\x20to\x20be\x20<strong>more\x20productive</strong>\x20than\x20ondansetron\x20in\x20the\x20management\x20of\x20<strong>PONV</strong>.</p>','explanation_video':'','question_images':[],'explanation_images':[_0x2a1f1a(0x1c9)]},{'text':'An\x20HIV\x20patient\x20developed\x20a\x20fever\x20and\x20dry\x20cough.\x20He\x20was\x20diagnosed\x20with\x20TB.\x20He\x20is\x20currently\x20on\x20Lamivudine,\x20Zidovudine\x20and\x20Nevirapine.\x20Which\x20Anti\x20-TB\x20drug\x20should\x20be\x20changed\x20in\x20this\x20patient?','choices':[{'id':0x1,'text':_0x2a1f1a(0x231)},{'id':0x2,'text':_0x2a1f1a(0x217)},{'id':0x3,'text':_0x2a1f1a(0x297)},{'id':0x4,'text':_0x2a1f1a(0xce)}],'correct_choice_id':0x2,'solution':_0x2a1f1a(0xab),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x2c8),'choices':[{'id':0x1,'text':_0x2a1f1a(0xe9)},{'id':0x2,'text':_0x2a1f1a(0xfd)},{'id':0x3,'text':_0x2a1f1a(0x2f9)},{'id':0x4,'text':_0x2a1f1a(0x2b7)}],'correct_choice_id':0x1,'solution':'<p><strong>Dicyclomine</strong>\x20is\x20a\x20weak\x20muscarinic\x20receptor\x20antagonist\x20with\x20non-specific\x20<strong>direct\x20spasmolytic</strong>\x20effects\x20on\x20the\x20smooth\x20muscle\x20of\x20the\x20gastrointestinal\x20tract.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Scopolamine</strong>\x20exerts\x20<strong>spasmolytic\x20activity</strong>\x20indirectly\x20through\x20its\x20<strong>antimuscarinic\x20action</strong>.\x20It\x20is\x20not\x20preferred\x20due\x20to\x20its\x20adverse\x20effects\x20like\x20drowsiness,\x20dryness,\x20and\x20blurred\x20vision.\u00a0</p>\x0a<p>Option\x20C\x20and\x20D:\u00a0<strong>Galantamine</strong>\x20and\x20<strong>rivastigmine</strong>\x20are\x20<strong>central\x20cholinesterase\x20inhibitors</strong>\x20and\x20do\x20not\x20possess\x20spasmolytic\x20activity.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x2d1),'choices':[{'id':0x1,'text':_0x2a1f1a(0x290)},{'id':0x2,'text':_0x2a1f1a(0x2c2)},{'id':0x3,'text':'Chance\x20of\x20abortion\x20in\x203\x20HP\x20is\x20same\x20as\x206H'},{'id':0x4,'text':_0x2a1f1a(0x220)}],'correct_choice_id':0x1,'solution':_0x2a1f1a(0x1c4),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x2d0),'choices':[{'id':0x1,'text':_0x2a1f1a(0x2c3)},{'id':0x2,'text':_0x2a1f1a(0x2a6)},{'id':0x3,'text':_0x2a1f1a(0xc3)},{'id':0x4,'text':_0x2a1f1a(0x2df)}],'correct_choice_id':0x1,'solution':_0x2a1f1a(0x309),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x2ca),'choices':[{'id':0x1,'text':_0x2a1f1a(0x213)},{'id':0x2,'text':_0x2a1f1a(0x12c)},{'id':0x3,'text':_0x2a1f1a(0x1d5)},{'id':0x4,'text':_0x2a1f1a(0xe3)}],'correct_choice_id':0x2,'solution':_0x2a1f1a(0xa7),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/f29f9fa43ba346a29a54c1f5a649c32c.JPEG'],'explanation_images':[_0x2a1f1a(0x16a),_0x2a1f1a(0x169),_0x2a1f1a(0x190)]},{'text':_0x2a1f1a(0x16f),'choices':[{'id':0x1,'text':'Doxylamine'},{'id':0x2,'text':_0x2a1f1a(0x161)},{'id':0x3,'text':'Promethazine'},{'id':0x4,'text':'Astemizole'}],'correct_choice_id':0x4,'solution':_0x2a1f1a(0x28a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20child\x20was\x20started\x20on\x20ciclesonide\x20inhalational\x20therapy\x20for\x20bronchial\x20asthma.\x20Which\x20of\x20the\x20following\x20statements\x20is\x20incorrect\x20regarding\x20his\x20treatment?','choices':[{'id':0x1,'text':'It\x20has\x20fewer\x20side\x20effects\x20compared\x20to\x20other\x20inhalational\x20steroids'},{'id':0x2,'text':_0x2a1f1a(0x159)},{'id':0x3,'text':_0x2a1f1a(0x13a)},{'id':0x4,'text':'Oral\x20bioavailability\x20is\x20negligible'}],'correct_choice_id':0x3,'solution':_0x2a1f1a(0x2b8),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x33d),'choices':[{'id':0x1,'text':'Nicotinamide'},{'id':0x2,'text':_0x2a1f1a(0x1fe)},{'id':0x3,'text':'Ezetemibe'},{'id':0x4,'text':_0x2a1f1a(0x171)}],'correct_choice_id':0x1,'solution':_0x2a1f1a(0x130),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0xf7),'choices':[{'id':0x1,'text':_0x2a1f1a(0xf9)},{'id':0x2,'text':_0x2a1f1a(0x32d)},{'id':0x3,'text':'It\x20antagonizes\x20the\x20side\x20effect\x20of\x20Diphenoxylate'},{'id':0x4,'text':_0x2a1f1a(0x15e)}],'correct_choice_id':0x2,'solution':_0x2a1f1a(0x2d8),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x134),'choices':[{'id':0x1,'text':_0x2a1f1a(0x9e)},{'id':0x2,'text':'Atenolol'},{'id':0x3,'text':'Clonidine'},{'id':0x4,'text':'Enalapril'}],'correct_choice_id':0x3,'solution':_0x2a1f1a(0x240),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x141),'choices':[{'id':0x1,'text':_0x2a1f1a(0x2cf)},{'id':0x2,'text':'Phase\x20II'},{'id':0x3,'text':_0x2a1f1a(0x2f2)},{'id':0x4,'text':_0x2a1f1a(0x216)}],'correct_choice_id':0x1,'solution':'<p>The\x20<strong>dosing</strong>\u00a0of\x20a\x20new\x20drug\x20is\x20tested\x20in\x20<strong>phase\x20I\x20</strong>of\x20a\x20clinical\x20trial.</p>\x0a<p>Phase\x20I\x20trials\x20are\x20usually\x20performed\x20on<strong>\x20healthy\x20volunteers\x20</strong>to\x20check\x20the<strong>\x20safety\x20</strong>and\x20<strong>pharmacokinetic\x20properties\x20</strong>of\x20a\x20drug.\x20The\x20participants\x20in\x20this\x20phase\u00a0do\x20not\x20gain\x20any\x20direct\x20health\x20benefits\x20from\x20taking\x20part.\x20They\x20are\x20generally\x20<strong>paid\x20a\x20fee\x20</strong>for\x20their\x20time,\x20with\x20the\x20payments\x20being\x20regulated\x20and\x20not\x20related\x20to\x20the\x20risk\x20involved.</p>\x0a<p>In\x20clinical\x20trials,\x20<strong>drug\x20dosing</strong>\x20typically\x20occurs\x20in\x20Phase\x20I,\x20where\x20researchers\x20establish\x20the\x20<strong>optimal\x20dose</strong>\x20to\x20achieve\x20desired\x20effects\x20while\x20<strong>minimizing\x20side\x20effects</strong>.\x20In\x20these\x20phases,\x20they\x20focus\x20on\x20s<strong>afety,\x20tolerability,</strong>\x20and\x20<strong>pharmacokinetics</strong>.</p>\x0a<p><strong>Dose-ranging</strong>,\x20primarily\x20conducted\x20in\x20<strong>Phase\x20II\x20trials</strong>,\x20involves\x20<strong>testing\x20multiple\x20doses</strong>\x20to\x20identify\x20the\x20<strong>most\x20effective</strong>\x20and\x20<strong>safe\x20dose\x20range</strong>.\x20This\x20phase\x20helps\x20determine\x20the\x20<strong>minimum\x20effective\x20dose</strong>\x20and<strong>\x20maximum\x20tolerated\x20dose</strong>,\x20providing\x20critical\x20data\x20for\x20subsequent\x20studies\x20in\x20Phase\x203,\x20where\x20the\x20chosen\x20dose\x20is\x20tested\x20for\x20efficacy\x20and\x20safety\x20in\x20a\x20larger\x20population.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x2a1f1a(0x9d),'choices':[{'id':0x1,'text':_0x2a1f1a(0xc5)},{'id':0x2,'text':_0x2a1f1a(0xb4)},{'id':0x3,'text':_0x2a1f1a(0x2dc)},{'id':0x4,'text':'GMP'}],'correct_choice_id':0x3,'solution':'<p><strong>TMP\x20synthesis\x20</strong>is\u00a0<strong>affected\x20</strong>due\x20to<strong>\x20methotrexate.\u00a0</strong></p>\x0a<p><strong>Methotrexate</strong>\x20inhibits\x20<strong>dihydrofolate\x20reductase</strong>\x20(DHFR),\x20which\x20is\x20required\x20to\x20<strong>synthesize\x20tetrahydrofolate.\x20Tetrahydrofolate</strong>\x20is\x20essential\x20for\x20converting\x20<strong>dUMP</strong>\x20to\x20<strong>dTMP</strong>\x20(thymidine\x20monophosphate)\x20in\x20the\x20<strong>nucleotide\x20synthesis</strong>\x20pathway.\x20Therefore,\x20the\x20<strong>nucleotide\x20synthesis</strong>\x20affected\x20in\x20this\x20patient\x20is\x20<strong>TMP\x20(thymidine\x20monophosphate).</strong></p>\x0a<p>By\x20inhibiting\x20DHFR,\x20methotrexate\x20<strong>reduces</strong>\x20the\x20<strong>availability</strong>\x20of\x20<strong>THF,</strong>\x20thereby\x20disrupting\x20the\x20production\x20of\x20<strong>thymidylate</strong>\x20(TMP),\x20which\x20is\x20necessary\x20for\x20<strong>DNA\x20replication</strong>\x20and\x20<strong>repair.</strong>\x20This\x20disruption\x20leads\x20to\x20<strong>impaired\x20DNA\x20synthesis</strong>\x20in\x20rapidly\x20dividing\x20cells,\x20such\x20as\x20cancer\x20cells.\x20However,\x20it\x20also\x20affects\x20other\x20rapidly\x20dividing\x20cells,\x20including\x20those\x20in\x20the\x20<strong>gastrointestinal</strong>\x20tract\x20and\x20<strong>oral\x20mucosa,</strong>\x20leading\x20to\x20<strong>side\x20effects</strong>\x20like\x20<strong>oral</strong>\x20and\x20<strong>gastric\x20ulcers.</strong></p>','explanation_video':'','question_images':[],'explanation_images':[_0x2a1f1a(0x175)]},{'text':_0x2a1f1a(0x273),'choices':[{'id':0x1,'text':_0x2a1f1a(0x17e)},{'id':0x2,'text':'Somatropin'},{'id':0x3,'text':_0x2a1f1a(0xda)},{'id':0x4,'text':_0x2a1f1a(0x11f)}],'correct_choice_id':0x3,'solution':_0x2a1f1a(0x23a),'explanation_video':'','question_images':[],'explanation_images':[]}],quizName='060\x20Pharmacology\x20Neet\x202024',hierarchy=[_0x2a1f1a(0x31a),_0x2a1f1a(0x21f),_0x2a1f1a(0x20a)];if(window[_0x2a1f1a(0xdd)][_0x2a1f1a(0x2aa)][_0x2a1f1a(0x30f)](_0x2a1f1a(0xe7))){const customData=JSON[_0x2a1f1a(0x27f)](localStorage[_0x2a1f1a(0x1f9)](_0x2a1f1a(0x24e)));if(customData){const PyRalf=_0x2a1f1a(0x338)['split']('|');let xTvBOx=0x0;while(!![]){switch(PyRalf[xTvBOx++]){case'0':quizName=customData[_0x2a1f1a(0x142)];continue;case'1':questionsData=customData[_0x2a1f1a(0x1c7)];continue;case'2':document['getElementById'](_0x2a1f1a(0x26e))[_0x2a1f1a(0x113)]=hierarchy[_0x2a1f1a(0x2e9)](_0x2a1f1a(0x317));continue;case'3':hierarchy=customData[_0x2a1f1a(0x2ae)];continue;case'4':document[_0x2a1f1a(0x284)](_0x2a1f1a(0x30e))[_0x2a1f1a(0x113)]=questionsData[_0x2a1f1a(0x17f)];continue;case'5':document[_0x2a1f1a(0x245)]=quizName+'\x20-\x20Brain\x20And\x20Scalpel';continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x2a1f1a(0xc7),timer=null,timeRemaining=0x0,questionStartTime=Date['now'](),quizStartTime=Date[_0x2a1f1a(0xfc)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x2a1f1a(0x17f)])['fill'](null)[_0x2a1f1a(0x2fe)](()=>({'status':'not_attempted','bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x2a1f1a(0x17f)]};const urlParams=new URLSearchParams(window[_0x2a1f1a(0xdd)][_0x2a1f1a(0x305)]);currentQuestionIndex=Math[_0x2a1f1a(0x260)](parseInt(urlParams[_0x2a1f1a(0xba)](_0x2a1f1a(0x308)))||0x0,questionsData[_0x2a1f1a(0x17f)]-0x1);function goBack(){const _0x504a46=_0x2a1f1a,_0x138a79={'MvAKl':function(_0x17f2e8,_0x556489){return _0x17f2e8(_0x556489);},'ViPqS':'Are\x20you\x20sure\x20you\x20want\x20to\x20leave\x20the\x20quiz?\x20Your\x20progress\x20will\x20be\x20lost.'};(isQuizCompleted||_0x138a79[_0x504a46(0xd0)](confirm,_0x138a79['ViPqS']))&&window[_0x504a46(0x237)]['back']();}function selectMode(_0x26f650){const _0x37cdbb=_0x2a1f1a,_0x4a7692={'eWPlU':function(_0x24f0ee){return _0x24f0ee();}};currentMode=_0x26f650,document['getElementById']('modeModal')[_0x37cdbb(0x2a1)][_0x37cdbb(0x2b1)]=_0x37cdbb(0x256),_0x4a7692[_0x37cdbb(0x32b)](initializeQuiz);}function _0x14a2(){const _0x4c5726=['gOVSU','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','explanation_audio_eng','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','No\x20solution\x20available.','jjFHJ','sCoZZ','LlaxV','MVCfZ','aIaUK','RKOXE','cKVXA','answered','questionMedia','video[data-src]','not_attempted','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','IXboP','azGbk','AJQKw','HHKco','Responds\x20to\x20Monteleukast','QStGo','There\x20is\x20no\x20allergic\x20sensitization\x20to\x20aspirin\x20and\x20its\x20metabolites','ucPKd','</span><span>','SOATq','testModeLegend','DGzAo','return\x20(function()\x20','explanationVideoPlayer','DwkeP','ZybLu','uKZvR','wWqGO','XDCUm','dJTqv','correctResult','solution','nbCBA','lOxqq','</span></div>','iYopi','yuSOH','bookmarked','<p>The\x203HP\x20regimen,\x20which\x20involves\x20<strong>once-weekly</strong>\x20doses\x20of\x20<strong>Isoniazid</strong>\x20and\x20<strong>Rifapentine</strong>\x20for\x20<strong>12</strong>\x20<strong>weeks</strong>,\x20has\x20been\x20found\x20to\x20have\x20<strong>higher\x20patient\x20compliance</strong>\x20than\x20the\x20<strong>9-month</strong>\x20regimen\x20of\x20<strong>Isoniazid\x20(9H)</strong>\x20and\x20the\x20<strong>6-month\x20regimen\x20(6H).</strong></p>\x0a<p>The\x20<strong>shorter\x20duration</strong>\x20and\x20<strong>reduced\x20number</strong>\x20of\x20<strong>doses</strong>\x20in\x20the\x203HP\x20regimen\x20make\x20it\x20more\x20<strong>convenient</strong>\x20and\x20thus\x20lead\x20to\x20better\x20<strong>adherence.</strong>\x20Studies\x20have\x20shown\x20that\x20patients\x20are\x20more\x20likely\x20to\x20complete\x20the\x203HP\x20regimen\x20due\x20to\x20the\x20shorter\x20treatment\x20duration\x20and\x20lower\x20pill\x20burden.</p>\x0a<p>TPT\x20stands\x20for\x20<strong>Tuberculosis\x20Preventive\x20Therapy.</strong>\x20It\x20is\x20a\x20treatment\x20given\x20to\x20individuals\x20who\x20are\x20at\x20<strong>high\x20risk</strong>\x20of\x20<strong>developing\x20active\x20tuberculosis</strong>\x20(TB)\x20to\x20prevent\x20the\x20progression\x20from\x20latent\x20TB\x20infection\x20(where\x20the\x20person\x20is\x20infected\x20with\x20the\x20TB\x20bacteria\x20but\x20does\x20not\x20have\x20symptoms)\x20to\x20active\x20TB\x20disease.</p>\x0a<p>There\x20are\x20different\x20regimens\x20for\x20TPT,\x20including:</p>\x0a<ul>\x0a<li>3HP:\x20A\x20regimen\x20consisting\x20of\x20<strong>once-weekly</strong>\x20doses\x20of\x20<strong>Isoniazid</strong>\x20(H)\x20and\x20<strong>Rifapentine</strong>\x20(P)\x20for\x20<strong>12\x20weeks.</strong></li>\x0a<li>6H:\x20A\x20regimen\x20consisting\x20of\x20daily\x20Isoniazid\x20for\x206\x20months.</li>\x0a<li>9H:\x20A\x20regimen\x20consisting\x20of\x20daily\x20Isoniazid\x20for\x209\x20months.</li>\x0a</ul>\x0a<p>TPT\x20is\x20particularly\x20important\x20for\x20individuals\x20with\x20latent\x20TB\x20who\x20have\x20a\x20higher\x20risk\x20of\x20developing\x20active\x20TB,\x20such\x20as\x20those\x20with\x20HIV,\x20close\x20contacts\x20of\x20TB\x20patients,\x20or\x20those\x20with\x20certain\x20medical\x20conditions\x20that\x20weaken\x20the\x20immune\x20system.</p>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>Option\x20B:\x20Research\x20has\x20demonstrated\x20that\x20the\x203HP\x20regimen\x20offers\x20better\x20compliance\x20and\x20similar\x20<strong>effectiveness</strong>\x20compared\x20to\x20the\x20traditional\x206H\x20and\x209H\x20regimens.\x20The\x20shorter\x20duration\x20of\x203HP\x20(once\x20weekly\x20for\x2012\x20weeks)\x20makes\x20it\x20more\x20convenient\x20and\x20tolerable\x20for\x20patients,\x20which\x20leads\x20to\x20higher\x20adherence\x20rates.\x20Thus,\x20there\x20is\x20a\x20significant\x20difference\x20in\x20patient\x20compliance\x20between\x20these\x20regimens,\x20with\x203HP\x20showing\x20clear\x20advantages.</p>\x0a<p>Option\x20C:\x20Although\x20<strong>3HP</strong>\x20is\x20generally\x20considered\x20<strong>safe,</strong>\x20data\x20suggests\x20that\x20the\x20risk\x20profile\x20for\x20adverse\x20effects,\x20including\x20<strong>potential\x20reproductive</strong>\x20impacts\x20like\x20abortion,\x20differs\x20between\x20regimens.\x20Specifically,\x206H\x20may\x20have\x20a\x20different\x20side\x20effect\x20profile\x20due\x20to\x20the\x20<strong>prolonged\x20exposure</strong>\x20to\x20the\x20drug\x20over\x20six\x20months,\x20compared\x20to\x20the\x20shorter\x20and\x20intermittent\x20dosing\x20of\x203HP.\u00a0</p>\x0a<p>Option\x20D:\x20Studies\x20have\x20confirmed\x20that\x20the\x203HP\x20regimen\x20is\x20<strong>as\x20effective</strong>\x20as\x206H\x20and\x209H\x20in\x20preventing\x20active\x20tuberculosis\x20(TB).\x20Both\x20regimens\x20aim\x20to\x20prevent\x20<strong>latent\x20TB</strong>\x20from\x20<strong>progressing</strong>\x20to\x20<strong>active\x20disease,</strong>\x20and\x20<strong>3HP</strong>\x20has\x20been\x20shown\x20to\x20achieve\x20similar\x20outcomes\x20with\x20fewer\x20doses,\x20enhancing\x20patient\x20compliance.</p>','kUrCI','dkiTq','questions','jNHQx','https://dhmbxeygs57ff.cloudfront.net/uploads/412d569ccab6464c923b959231b29e98x512x371.PNG','612869QiREMm','bDlym','18qTKyTC','solutionImages','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','FDXJu','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','wZdhQ','htxbb','performanceModal','HGDIL','Adenosine\x200.2\x20mg/kg','vCndq','nRVnS','timeSpent','RLbtU','xTRiH','lcWhF','AJHzQ','jKIbj','sPMfc','GRToc','IUWUF','CZrPu','isSupported','questionText','flRup','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','strokeDashoffset','gKSaC','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','notAttempted','31984YxcVjF','HBySn','SuImc','hidden','test','getAttribute','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','kUVeJ','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','fyENv','bind','Bookmark','cLrRT','questionIndex','GnHgs','getItem','modeModal','295hSpMTp','pXxqe','vjeNu','Rosuvastatin','QvWRb','TXaJC','JcKfF','WtIzJ','loadSource','KlDHC','OBJPu','JgYPS','timerContainer','Unguv','warn','Pharmacology','ZrrEA','GyJJq','qCByH','NrIZc','iZEyt','IjRKs','table','wuOOL','Synchronized\x20cardioversion\x20with\x202J\x20of\x20current','xNsMk','styHm','Phase\x20IV','Rifampicin','\x22\x20data-src=\x22','nRnpD','upTcE','kIiAW','XWJsA','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','jcroK','PYQs','3HP\x20regimen\x20is\x20less\x20effective\x20than\x206H\x20and\x209H\x20in\x20preventing\x20active\x20TB','ZiPkf','selectedAnswer','apply','correct_choice_id','markedForReview','LNEaj','Doxorubicin\x20+\x20Idarubicin','quizFile','Lnsso','aePfy','preventDefault','JmSUG','A\x207-year-old\x20boy\x20presents\x20with\x20a\x20two-week\x20history\x20of\x20persistent\x20fever,\x20fatigue,\x20and\x20pallor.\x20His\x20parents\x20also\x20report\x20easy\x20bruising\x20and\x20gum\x20bleeding.\x20On\x20examination,\x20he\x20is\x20pale\x20with\x20petechiae\x20on\x20his\x20legs,\x20hepatosplenomegaly,\x20and\x20generalized\x20lymphadenopathy.\x20Blood\x20tests\x20show\x20severe\x20anemia,\x20thrombocytopenia,\x20and\x20elevated\x20white\x20blood\x20cell\x20count\x20with\x20blast\x20cells.\x20What\x20is\x20the\x20most\x20appropriate\x20initial\x20treatment\x20regimen\x20for\x20this\x20patient?','\x20-\x20Brain\x20And\x20Scalpel','nZKVl','HEmbT','Isoniazid','findIndex','FZqzd','BITyn','pRhdR','NUhOU','history','incorrectCount','IDUJI','<p><strong>Tesamorelin</strong>\x20is\x20approved\x20for\x20use\x20in\x20<strong>HIV-associated\x20lipodystrophy</strong>\x20but\x20<strong>not</strong>\x20for\x20<strong>GH\x20deficiency</strong>.\x20It\x20is\x20a<strong>\x20synthetic\x20N-terminal\x20modified\x20</strong>form\x20of\x20human\x20GHRH<strong>.</strong>\x20It\x20does\x20not\x20get\x20degraded\x20by\x20dipeptidyl\x20peptidase\x204\x20and\x20therefore\x20has\x20a\x20longer\x20duration\x20of\x20action.</p>\x0a<p>It\x20increases\x20the\x20levels\x20of\x20growth\x20hormone\x20(GH)\x20and\x20insulin-like\x20growth\x20factor\x20(IGF-1)\x20but\x20reduces\x20visceral\x20fat\x20accumulation.</p>\x0a<p>Tesamorelin\x20is\x20approved\x20for\x20use\x20in\x20HIV-associated\x20lipodystrophy\x20but\x20<strong>not</strong>\x20for\x20<strong>GH</strong>\u00a0<strong>deficiency.</strong>\u00a0</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Octreotide\u00a0</strong>is\x20a\x20<strong>somatostatin\x20analogue</strong>\x20that\x20decreases\x20growth\x20hormone\x20levels.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20<strong>acromegaly</strong>,\x20<strong>variceal\x20bleeding,</strong>\x20diarrhoea\x20due\x20to\x20adenomas\x20secreting\x20VIP\x20(vasoactive\x20intestinal\x20peptide),\x20and\x20<strong>sulfonylurea\x20toxicity.</strong>\x20One\x20of\x20its\x20adverse\x20effects\x20is\x20<strong>gallstone</strong>\x20formation.</p>\x0a<p>Option\x20B:\x20<strong>Somatropin\u00a0</strong>is\x20a\x20<strong>growth\x20hormone\x20analogue</strong>.\x20It\x20is\x20used\x20in\x20growth\x20hormone\x20deficiency\x20and\x20other\x20short-stature\x20conditions\x20like\x20Turner\x27s\x20syndrome,\x20Noonan\x20syndrome,\x20and\x20Prader-Willi\x20syndrome.\x20Their\x20use\x20is\x20contraindicated\x20in\x20acute\x20critical\x20illness,\x20active\x20malignancy,\x20and\x20proliferative\x20retinopathy.</p>\x0a<p>Option\x20D:\x20<strong>Mecasermin\u00a0</strong>is\x20a\x20<strong>recombinant\x20human\x20IGF-1</strong>.\x20It\x20is\x20used\x20in\x20IGF-1\x20deficiency,\x20growth\x20hormone\x20receptor\x20defects,\x20and\x20antibodies\x20against\x20growth\x20hormone\x20receptors.\x20Adverse\x20effects\x20include\x20<strong>hypoglycemia</strong>\x20and\x20<strong>lipohypertrophy</strong>.\x20Another\x20recombinant\x20human\x20IGF-1\x20with\x20its\x20IGFBP-3,\x20<strong>mecasermin\x20rinfabate</strong>\x20has\x20been\x20FDA-approved\x20for\x20<strong>HIV-associated\x20adipose\x20redistribution\x20syndrome</strong>.</p>','ArrowLeft','rkbgS','lnjje','NK-2\x20agonist','Bzftz','<p>The<strong>\x20adverse\x20effects</strong>\x20seen\x20in\x20this\x20patient\x20and\x20the\x20presentation\x20of\x20<strong>rebound\x20hypertension</strong>\x20on\x20<strong>sudden\x20drug\x20withdrawal</strong>\x20indicate\x20that\x20the\x20drug\x20is\x20<strong>clonidine</strong>.\u00a0</p>\x0a<p>Clonidine\x20is\x20an\u00a0<strong>alpha-2\x20receptor\x20agonist</strong>\x20and\x20a\u00a0centrally-acting\x20<strong>antihypertensive</strong>\x20agent.\u00a0It\x20treats\x20high\x20blood\x20pressure\x20by\x20stimulating\x20<strong>presynaptic\x20α<sub>2</sub>\x20receptors</strong>\x20in\x20the\x20vasomotor\x20center\x20in\x20the\x20brainstem.\x20This\x20binding\x20has\x20a\x20<strong>sympatholytic</strong>\x20<strong>effect</strong>,\x20by\x20<strong>suppressing\x20</strong>the\x20release\x20of\x20<strong>norepinephrine</strong>\x20and\x20other\x20sympathomimetics.</p>\x0a<p>Abrupt\x20withdrawal\x20after\x20long-term\x20therapy\x20can\x20result\x20in\x20<strong>rebound\x20hypertension,\u00a0</strong>restlessness,\x20and\x20sympathetic\x20overactivity.\u00a0<strong>Dry\x20mouth</strong>\x20and\x20<strong>sedation</strong>\x20are\x20the\x20major\x20side\x20effects\x20of\x20clonidine.\x20It\x20can\x20also\x20cause\x20<strong>impotency</strong>\x20and\x20<strong>constipation.\x20Rebound\x20hypertension\x20</strong>is\x20a\x20potentially\x20serious\x20complication\x20and\x20occurs<strong>\u00a0</strong>if\x20the\x20drug\x20is\x20<strong>missed</strong>\x20for<strong>\x201–2\x20days</strong>.\x20This\x20is\x20associated\x20with\x20an<strong>\x20alarming\x20rise\x20</strong>in\x20<strong>blood\x20pressure\x20</strong>which\x20may\x20be\x20<strong>more</strong>\x20than\x20the<strong>\x20pretreatment\x20level.</strong></p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20171\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p><strong>Phentolamine</strong>\x20is\x20used\x20for\x20the\x20control\x20of\x20hypertension\x20due\x20to\x20clonidine\x20withdrawal.</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','FNbRf','QNgSd','oWJmM','title','UBoSj','oHKsD','HAVNx','<p>The\x20drug\x20used\x20to\x20treat\x20<strong>multiple\x20myeloma\x20</strong>and\x20that\x20has\x20the\x20potential\x20to\x20cause<strong>\u00a0reactivation</strong>\x20of\x20<strong>Herpes\x20Zoster</strong>\x20is\x20<strong>bortezomib</strong>.</p>\x0a<p>Bortezomib\x20is\x20an\x20<strong>inhibitor\x20</strong>of\x20<strong>proteasome-mediated\x20protein\x20degradation</strong>.\x20It\x20is\x20central\x20to\x20the\x20treatment\x20of\x20<strong>multiple\x20myeloma</strong>,\x20both\x20untreated\x20and\x20relapsed.\x20Bortezomib\x20is\x20given\x20<strong>intravenously\x20or\x20subcutaneously</strong>\x20and\x20dosage\x20depends\x20upon\x20the\x20disease,\x20route\x20of\x20administration,\x20and\x20the\x20patient’s\x20history.\u00a0\x20It\x20is\x20known\x20to\x20predispose\x20patients\x20to\x20the\x20<strong>reactivation</strong>\x20of<strong>\x20herpesvirus</strong>,\x20including\x20<strong>Herpes\x20Zoster</strong>.</p>\x0a<p>Adverse\x20effects\x20include\x20<strong>thrombocytopenia</strong>,\x20fatigue,\x20<strong>peripheral\x20neuropathy</strong>,\x20neutropenia,\x20anaemia,\x20anorexia,\x20nausea,\x20limb\x20pain,\x20dizziness,\x20etc.\x20Other\x20adverse\x20events\x20like\x20cardiac\x20tamponade,\x20disseminated\x20intravascular\x20coagulation,\x20toxic\x20epidermal\x20necrolysis,\x20etc.\x20have\x20been\x20reported.\u00a0</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Lenalidomide</strong>\x20is\x20the\x20<strong>drug\x20of\x20choice</strong>\x20in\x20patients\x20with\x20<strong>myelodysplastic\x20syndrome\x20(MDS)</strong>\x20associated\x20with\x20<strong>5q\x20deletion</strong>,\x20and\x20is\x20an\x20<strong>immunomodulatory\x20analogue</strong>\x20of\x20<strong>thalidomide</strong>.\x20It\x20<strong>suppresses\x20bone\x20marrow</strong>\x20and\x20is\x20often\x20associated\x20with\x20<strong>significant\x20leukopenia</strong>.</p>\x0a<p>Option\x20C:\x20<strong>Daratumumab</strong>\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20against\x20<strong>CD-38</strong>.\u00a0</p>\x0a<p>Option\x20D:\x20<strong>Elotuzumab</strong>\x20is\x20a\x20<strong>monoclonal\x20antibody</strong>\x20against\x20<strong>SLAMF7</strong>,\x20a\x20glycoprotein\x20expressed\x20in\x20<strong>multiple\x20myeloma\x20cells\x20</strong>and\x20<strong>natural\x20killer\x20cells</strong>.\x20It\x20is\x20used\x20in\x20<strong>combination</strong>\x20with\x20<strong>lenalidomide</strong>\x20and\x20<strong>dexamethasone</strong>\x20for\x20the\x20treatment\x20of\x20<strong>multiple\x20myeloma</strong>.</p>','A\x2075-year-old\x20female\x20presented\x20with\x20urinary\x20incontinence.\x20She\x20also\x20has\x20cognition\x20decline\x20and\x20dementia.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20useful\x20for\x20treating\x20urinary\x20incontinence?','fdCug','nOOfX','console','customQuizData','qiTVG','toggle','Daratumumab','Clopidogrel','Xwhgh','ClRkj','jopwC','none','4\x20tablets\x20of\x20Artesunate\x2050mg\x20+\x206\x20tablets\x20of\x20Primaquine\x207.5mg','HpLcx','Radiotherapy\x20of\x20lymph\x20nodes','question_audio','YbJLu','biqqX','dyPTU','veZlB','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','min','187274JUiCoi','innerHTML','bookmarkText','4\x20tablets\x20of\x20Artesunate\x2050mg\x20+\x20Sulphadoxine\x201500mg\x20+\x206\x20tablets\x20of\x20Primaquine\x202.5mg','dsaTb','Rdbut','4\x20tablets\x20of\x20Artesunate\x2045mg\x20+\x20Sulphadoxine\x201500mg\x20\x20+\x206\x20tablets\x20of\x20Primaquine\x207.5mg','mzcmt','Buprenorphine','oygXV','solutionText','Naloxone','LLUBW','quizHierarchy','lnlyQ','qunNU','incorrectResult','appendChild','The\x20drug\x20\x27X\x27\x20is\x20a\x20GHRH\x20analogue\x20that\x20is\x20FDA-approved\x20for\x20the\x20treatment\x20of\x20HIV-associated\x20lipodystrophy\x20and\x20not\x20used\x20for\x20Growth\x20hormone\x20deficiency.\x20Identify\x20the\x20drug\x20\x27X\x27.','questionNav','fBMwc','FXWyW','730149HCjEQg','kqLWj','reduce','Occurs\x20with\x20exposure\x20to\x20other\x20NSAIDs\x20too\x20that\x20block\x20COX\x201','bRvMX','<p>For\x20managing\x20<strong>urinary\x20incontinence</strong>\x20in\x20a\x2075-year-old\x20female\x20with\x20<strong>cognitive\x20decline</strong>\x20and\x20<strong>dementia</strong>,\x20<strong>tolterodine</strong>\x20is\x20useful.</p>\x0a<p>Tolterodine\x20is\x20a\x20<strong>muscarinic\x20receptor\x20antagonist</strong>\x20specifically\x20effective\x20for\x20treating\x20urinary\x20incontinence.\x20It\x20exhibits\x20selectivity\x20for\x20the\x20urinary\x20bladder,\x20which\x20helps\x20to\x20minimize\x20side\x20effects\x20compared\x20to\x20other\x20antimuscarinic\x20agents.\x20This\x20selectivity\x20is\x20<strong>beneficial</strong>\x20for\x20patients\x20with\x20<strong>cognitive\x20decline\x20</strong>or\x20dementia,\x20as\x20it\x20<strong>reduces\x20</strong>the\x20risk\x20of\x20<strong>adverse\x20effects.</strong>\x20Tolterodine\x20is\x20<strong>metabolized</strong>\x20by\x20<strong>CYP2D6</strong>,\x20so\x20its\x20dosage\x20may\x20need\x20adjustment\x20based\x20on\x20individual\x20CYP2D6\x20activity,\x20making\x20it\x20a\x20suitable\x20option\x20for\x20managing\x20urinary\x20incontinence\x20while\x20minimizing\x20potential\x20side\x20effects.</p>\x0a<p>Other\x20muscarinic\x20antagonists\x20for\x20urinary\x20incontinence\x20include\x20<strong>oxybutynin,\x20trospium\x20chloride,\x20darifenacin,\x20solifenacin</strong>,\x20and\x20<strong>fesoterodine</strong>.\x20<strong>Oxybutynin</strong>,\x20though\x20effective,\x20often\x20causes\x20antimuscarinic\x20side\x20effects\x20such\x20as\x20<strong>xerostomia</strong>.\x20<strong>Trospium</strong>\x20chloride,\x20being\x20a\x20quaternary\x20amine,\x20is\x20better\x20tolerated\x20and\x20<strong>excreted\x20primarily</strong>\x20via\x20the<strong>\x20kidneys</strong>,\x20requiring\x20dosage\x20adjustments\x20in\x20renal\x20impairment.\x20<strong>Darifenacin</strong>\x20and\x20<strong>solifenacin</strong>\x20have\x20selectivity\x20for<strong>\x20M3\x20receptors</strong>,\x20which\x20helps\x20balance\x20efficacy\x20and\x20side\x20effects,\x20while\x20<strong>fesoterodine</strong>,\x20a\x20<strong>prodrug</strong>,\x20provides\x20a\x20stable\x20pharmacokinetic\x20profile\x20due\x20to\x20its\x20<strong>conversion</strong>\x20to\x20<strong>tolterodine’s\x20active\x20metabolite</strong>.</p>\x0a<p>Other\x20Options:</p>\x0a<p>Option\x20A:\x20<strong>Tiotropium</strong>\x20and\x20Option\x20C:\x20<strong>Ipratropium</strong>\x20are\x20<strong>muscarinic\x20antagonists</strong>\x20used\x20primarily\x20for\x20respiratory\x20conditions\x20such\x20as\x20<strong>chronic\x20obstructive\x20pulmonary\x20disease\x20(COPD)</strong>\x20and\x20<strong>asthma</strong>,\x20rather\x20than\x20urinary\x20incontinence.\x20<strong>Tiotropium</strong>\x20is\x20a\x20<strong>long</strong>-acting\x20agent\x20with\x20selectivity\x20for\x20<strong>M1\x20</strong>and\x20<strong>M3</strong>\x20receptors,\x20while\x20<strong>Ipratropium</strong>\x20is\x20used\x20more\x20frequently\x20for\x20its<strong>\x20short</strong>-acting\x20effects.</p>\x0a<p>Option\x20D:\x20<strong>Telenzepine</strong>,\x20an\x20<strong>analogue</strong>\x20of\x20<strong>Pirenzepine</strong>,\x20displays\x20higher\x20potency\x20and\x20selectivity\x20for\x20<strong>M1</strong>\x20receptors\x20compared\x20to\x20pirenzepine\x20and\x20is\x20used\x20in\x20treating\x20<strong>acid-peptic\x20diseas</strong>e,\x20not\x20urinary\x20incontinence.\u00a0</p>','tEfuD','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','parse','No\x20solution\x20provided','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','FHGpA','1727DqvKWN','getElementById','ybiCr','HMmla','stringify','correct','addEventListener','<p>Among\x20the\x20given\x20drugs,\x20<strong>astemizole</strong>\x20increases\x20the\x20risk\x20of\x20Torsades\x20de\x20pointes\x20when\x20used\x20concomitantly\x20with\x20erythromycin.\u00a0</p>\x0a<p>Drugs\x20that\x20<strong>block\x20potassium\x20channels</strong>\x20and\x20prolong\x20<strong>QT\x20increase\x20arrhythmogenic</strong>\x20potential.\x20Astemizole\x20is\x20a\x20<strong>second-generation\x20antihistamine</strong>\x20that\x20<strong>blocks</strong>\x20delayed\x20potassium\x20channels\x20and\x20prolongs\x20the\x20QT\x20interval.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Doxylamine</strong>\x20is\x20an\x20<strong>antihistamine</strong>\x20commonly\x20used\x20as\x20a\x20<strong>short-term\x20treatment</strong>\x20for\x20<strong>insomnia.</strong>\x20It\x20is\x20combined\x20with\x20pyridoxine\x20(vitamin\x20B6)\x20to\x20treat\x20nausea\x20and\x20vomiting\x20during\x20pregnancy\x20(morning\x20sickness).\x20It\x20does\x20<strong>not</strong>\x20prolong\x20the\x20QT\x20interval.</p>\x0a<p><span\x20style=\x22font-family:\x20-apple-system,\x20BlinkMacSystemFont,\x20\x27Segoe\x20UI\x27,\x20Roboto,\x20Oxygen,\x20Ubuntu,\x20Cantarell,\x20\x27Open\x20Sans\x27,\x20\x27Helvetica\x20Neue\x27,\x20sans-serif;\x22>Option\x20B:\x20<strong>Loratadine</strong>\x20is\x20a\x20<strong>second-generation</strong>\x20antihistamine\x20used\x20to\x20treat\x20allergic\x20rhinitis\x20(hay\x20fever)\x20and\x20urticaria\x20(hives).\x20It\x20is\x20known\x20for\x20being\x20non-sedating\x20due\x20to\x20its\x20minimal\x20penetration\x20into\x20the\x20central\x20nervous\x20system.\x20It\x20does\x20<strong>not</strong>\x20prolong\x20the\x20QT\x20interval.</span></p>\x0a<p>Option\x20C:\x20<strong>Promethazine</strong>\x20is\x20a\x20<strong>first-generation</strong>\x20antihistamine\x20with\x20multiple\x20uses,\x20including\x20the\x20treatment\x20of\x20allergies,\x20motion\x20sickness,\x20nausea\x20and\x20vomiting,\x20and\x20as\x20a\x20sedative\x20or\x20sleep\x20aid.\x20It\x20also\x20has\x20antiemetic\x20properties\x20and\x20is\x20sometimes\x20used\x20in\x20the\x20management\x20of\x20<strong>postoperative\x20nausea</strong>\x20and\x20<strong>vomiting.</strong></p>','YWucm','cRVuj','jTlqG','NeJxV','{}.constructor(\x22return\x20this\x22)(\x20)','There\x20is\x20more\x20compliance\x20in\x203HP\x20than\x209H\x20and\x206H','border-gray-600','accuracy','push','HCmDe','Tiotropium','(((.+)+)+)+$','Streptomycin','className','xKgJC','Volume\x20of\x20distribution','ezcDr','canPlayType','OsTCm','totalQuestionsResult','statsBar','iexmG','style','ctuqC','KDdmq','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','VHyaN','Hydrochlorothiazide','unsrZ','RcWzh','quizSidebar','pathname','xUcLm','kqlvA','KNpdL','hierarchy','Ofajw','application/vnd.apple.mpegurl','display','Which\x20drug\x20is\x20used\x20for\x20maintenance\x20therapy\x20in\x20opium\x20addiction?','optionsContainer','zwpNj','UxfOz','explanation_audio_hin','Rivastigmine','<p>The\x20incorrect\x20statement\x20is\x20option\x20C\x20as\x20<strong>ciclesonide</strong>\x20has\x20a\x20<strong>lower\x20risk</strong>\x20of\x20<strong>oral\x20candidiasis</strong>\x20as\x20compared\x20to\x20<strong>other\x20inhaled\x20steroids</strong>.</p>\x0a<p><strong>Ciclesonide</strong>\x20is\x20an\x20<strong>inhaled\x20corticosteroid</strong>\x20that\x20is\x20unique\x20because\x20it\x20is\x20a\x20<strong>prodrug.</strong>\x20It\x20is\x20metabolised\x20by\x20<strong>bronchial\x20esterases</strong>\x20in\x20the\x20<strong>lungs</strong>\x20to\x20its\x20active\x20form,\x20which\x20allows\x20for\x20<strong>targeted\x20action</strong>\x20within\x20the\x20<strong>airways.</strong>\x20This\x20feature\x20<strong>reduces</strong>\x20<strong>systemic\x20side\x20effects</strong>\x20and\x20the\x20risk\x20of\x20<strong>local\x20side\x20effects,</strong>\x20such\x20as\x20<strong>oral\x20candidiasis</strong>\x20(thrush),\x20compared\x20to\x20other\x20inhaled\x20steroids.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20Ciclesonide\x27s\x20activation\x20in\x20the\x20lungs\x20minimises\x20systemic\x20absorption,\x20leading\x20to\x20fewer\x20side\x20effects.</p>\x0a<p>Option\x20B:\x20Ciclesonide\x20is\x20inactive\x20until\x20it\x20is\x20converted\x20to\x20its\x20active\x20form\x20in\x20the\x20lungs.</p>\x0a<p>Option\x20D:\x20Due\x20to\x20its\x20prodrug\x20nature\x20and\x20metabolism\x20in\x20the\x20lungs,\x20ciclesonide\x20has\x20low\x20oral\x20bioavailability,\x20reducing\x20systemic\x20exposure.</p>','CHrFU','dataset','HOyxl','iqKMB','<p>The\x20diagnosis\x20for\x20this\x20patient\x20with\x20<strong>breathing\x20difficulty</strong>\x20and\x20<strong>nasal\x20polyposis</strong>,\x20triggered\x20by\x20<strong>aspirin</strong>,\x20a\x20<strong>COX-1\x20inhibitor</strong>\x20is\x20<strong>aspirin-induced\x20asthma</strong>,\x20also\x20known\x20as\x20<strong>Samter\x27s\x20triad</strong>.\x20The\x20statement\x20that\x20is\x20not\x20true\x20is\x20that\x20\x22it\x20occurs\x20on\x20exposure\x20to\x20only\x20aspirin\x22,\x20as\x20this\x20condition\x20can\x20also\x20be\x20<strong>triggered</strong>\x20by\x20<strong>other\x20NSAIDs</strong>\x20that\x20<strong>inhibit\x20COX-1,</strong>\x20and\x20is\x20<strong>not</strong>\x20restricted\x20to\x20just\x20<strong>aspirin\x20alone</strong>.</p>\x0a<p><strong>Samter\x27s\x20triad\x20</strong>is\x20also\x20known\x20as\u00a0<strong>aspirin-induced\x20asthma\x20</strong>or\x20aspirin-sensitive\x20asthma<strong>.</strong>\u00a0It\x20consists\x20of:</p>\x0a<ul>\x0a<li><strong>Nasal\x20polyposis</strong></li>\x0a<li>Bronchial\x20<strong>asthma</strong></li>\x0a<li><strong>Aspirin\x20intolerance</strong></li>\x0a</ul>\x0a<p>A\x20patient\x20with\x20Samter\x27s\x20triad\x20experiences\x20severe\x20asthma\x20and\x20nasal\x20polyposis\x20triggered\x20by\x20aspirin\x20or\x20other\x20COX-1\x20inhibitors.\x20This\x20condition\x20involves\x20<strong>nasal\x20congestion,\x20rhinorrhea,\x20anosmia,</strong>\x20and\x20<strong>recurrent\x20chronic\x20rhinosinusitis</strong>,\x20with\x20<strong>acute\x20asthma\x20attacks</strong>\x20often\x20occurring\x20a\x20few\x20hours\x20after\x20ingestion\x20of\x20these\x20medications.</p>\x0a<p>These\x20patients\x20<strong>overproduce\x20leukotrienes</strong>\x20due\x20to\x20COX-1\x20inhibition\x20and\x20<strong>decreased\x20prostaglandin\x20E2\x20(PGE2)</strong>\x20levels.\x20Therefore,\x20they\x20should\x20<strong>avoid\x20COX-1\x20inhibitors</strong>\x20like\x20aspirin\x20and\x20most\x20NSAIDs\x20but\x20can\x20generally<strong>\x20tolerate\x20COX-2\x20inhibitors</strong>\x20and\x20<strong>acetaminophen</strong>.</p>\x0a<p>Treatment\x20typically\x20includes\x20<strong>leukotriene\x20modifiers</strong>,\x20and\x20in\x20some\x20cases,\x20<strong>aspirin\x20desensitization</strong>\x20may\x20be\x20used\x20to\x20manage\x20symptoms\x20and\x20allow\x20the\x20use\x20of\x20aspirin\x20or\x20NSAIDs\x20if\x20necessary\x20for\x20other\x20conditions.\x20Recent\x20advances\x20in\x20treatment\x20include\x20biologics\x20such\x20as\x20<strong>Dupilumab</strong>\x20and\x20<strong>IL-5\x20inhibitors</strong>,\x20which\x20are\x20increasingly\x20effective\x20in\x20managing\x20aspirin-induced\x20asthma\x20and\x20may\x20replace\x20aspirin\x20desensitization\x20except\x20when\x20ongoing\x20aspirin\x20or\x20NSAID\x20therapy\x20is\x20required.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20The\x20reaction\x20in\x20aspirin-induced\x20asthma\x20is\x20<strong>not</strong>\x20due\x20to\x20an\x20<strong>allergic\x20sensitization</strong>\x20but\x20rather\x20due\x20to\x20the\x20inhibition\x20of\x20COX-1\x20and\x20subsequent\x20overproduction\x20of\x20leukotrienes.</p>\x0a<p>Option\x20B:\x20<strong>Montelukast</strong>,\x20a\x20l<strong>eukotriene\x20receptor\x20antagonist,</strong>\x20is\x20effective\x20in\x20managing\x20symptoms\x20of\x20aspirin-induced\x20asthma\x20by\x20counteracting\x20the\x20elevated\x20levels\x20of\x20leukotrienes\x20that\x20contribute\x20to\x20inflammation\x20and\x20respiratory\x20issues.</p>\x0a<p>Option\x20D:\x20It\x20occurs\x20with\x20exposure\x20to\x20other\x20NSAIDs\x20too,\x20that\x20block\x20COX-1.\x20Patients\x20with\x20aspirin-induced\x20asthma\x20can\x20react\x20to\x20other\x20<strong>NSAIDs\x20</strong>that\x20<strong>inhibit\x20COX-1</strong>,\x20not\x20just\x20aspirin.\u00a0</p>','nxrRr','lPcQh','haczL','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','No\x20significant\x20difference\x20in\x203HP,\x206H,\x209H','Mannitol','SrhQA','yCOmL','jhQkR','Clearance','A\x2032-year-old\x20woman\x20diagnosed\x20with\x20diarrhoea-predominant\x20irritable\x20bowel\x20syndrome\x20presented\x20to\x20the\x20casualty\x20with\x20severe\x20abdominal\x20pain.\x20She\x20was\x20prescribed\x20a\x20drug\x20that\x20exerts\x20a\x20direct\x20spasmolytic\x20effect\x20on\x20the\x20smooth\x20muscles\x20of\x20the\x20gastrointestinal\x20tract.\x20Which\x20drug\x20could\x20it\x20be?','KKbxc','A\x202-year-old\x20child\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20lethargy,\x20difficulty\x20feeding,\x20and\x20dehydration.\x20His\x20vitals\x20are\x20stable\x20and\x20his\x20ECG\x20is\x20shown\x20below.\x20What\x20is\x20the\x20next\x20step\x20in\x20his\x20management?','zwdFF','qDkWN','hxXvY','No\x20questions\x20available\x20for\x20this\x20quiz.','Phase\x20I','A\x20female\x20suffered\x20a\x20head\x20injury\x20from\x20a\x20road\x20traffic\x20accident.\x20On\x20examination,\x20there\x20is\x20elevated\x20intracranial\x20pressure.\x20Which\x20diuretic\x20among\x20the\x20following\x20can\x20be\x20used\x20in\x20her\x20condition?','A\x20patient\x20is\x20started\x20on\x20a\x203\x20HP\x20TPT\x20regimen.\x20Which\x20of\x20the\x20following\x20is\x20true\x20regarding\x20the\x20regimen?','dmcxE','explanation_video','error','Butarphanol','osiUy','CSGKM','<p><strong>Atropine</strong>\x20is\x20included\x20in\x20combination\x20with\x20<strong>diphenoxylate</strong>\x20to\x20prevent\x20<strong>abuse</strong>\x20and\x20<strong>overdose</strong>\x20of\x20diphenoxylate.\u00a0</p>\x0a<p><strong>Diphenoxylate</strong>\x20is\x20structurally\x20similar\x20to\x20<strong>opioids</strong>\x20and\x20has\x20the\x20<strong>potential</strong>\x20for\x20<strong>misuse</strong>\x20at\x20<strong>higher\x20doses.</strong>\x20Additionally,\x20it\x20crosses\x20the\x20<strong>blood-brain</strong>\x20barrier,\x20making\x20it\x20more\x20likely\x20to\x20cause\x20dependence.\x20The\x20anticholinergic\x20effects\x20of\x20atropine\x20(e.g.,\x20dry\x20mouth,\x20tachycardia,\x20blurred\x20vision)\x20become\x20prominent\x20at\x20<strong>higher\x20doses,</strong>\x20discouraging\x20overdose.</p>\x0a<p><strong>Diphenoxylate</strong>\x20is\x20an\x20opioid\x20agonist\x20primarily\x20used\x20as\x20an\x20<strong>antidiarrheal</strong>\x20agent.\x20It\x20works\x20by\x20slowing\x20down\x20<strong>intestinal\x20motility,</strong>\x20allowing\x20more\x20time\x20for\x20water\x20and\x20<strong>electrolytes</strong>\x20to\x20be\x20absorbed\x20from\x20the\x20intestines,\x20which\x20helps\x20<strong>reduce\x20diarrhea.</strong>\x20However,\x20because\x20of\x20its\x20structural\x20similarity\x20to\x20opioids,\x20diphenoxylate\x20has\x20the\x20potential\x20for\x20abuse\x20and\x20dependence\x20if\x20taken\x20in\x20large\x20doses.</p>','KBYvo','incorrect','Ljzqx','TMP','IHVVd','qosZf','Acetazolamide','filter','zeDbY','reload','UnxFu','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','disabled','AiVRQ','PbhVz','rJjOR','join','add','raQgL','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','bookmarkBtn','uPPDG','wNIPP','vlrTc','split','Phase\x20III','Which\x20drug\x20is\x20used\x20to\x20treat\x20multiple\x20myeloma\x20that\x20is\x20known\x20to\x20cause\x20reactivation\x20of\x20Herpes\x20Zoster?','prototype','5|1|3|4|0|2','toString','querySelectorAll','pMXus','Galantamine','solutionContainer','aSuTU','click','DNyrr','map','scoreCircle','xDZGH','Plasma\x20half\x20life','aCqtB','QCztB','hqfqE','search','SSRtD','replace','startAt','<p>In\x20this\x20patient\x20with\x20<strong>raised\x20intracranial\x20pressure</strong>\x20after\x20a\x20<strong>road\x20traffic\x20accident,\x20mannitol</strong>\x20is\x20the\x20<strong>diuretic</strong>\x20of\x20<strong>choice</strong>\x20in\x20her\x20management\x20to\x20reduce\x20intracranial\x20pressure.\u00a0</p>\x0a<p>Mannitol\x20is\x20an\x20osmotic\x20diuretic\x20that\x20draws\x20<strong>fluid</strong>\x20out\x20of\x20the\x20<strong>brain\x20tissue</strong>\x20and\x20into\x20the\x20<strong>bloodstream</strong>\x20as\x20it\x20forms\x20a\x20<strong>hypertonic</strong>\x20solution\x20when\x20it\x20reaches\x20the\x20bloodstream,\x20thereby\x20reducing\x20intracranial\x20pressure\x20(ICP).\x20It\x20is\x20commonly\x20used\x20in\x20cases\x20of\x20<strong>traumatic\x20brain\x20injury</strong>\x20or\x20other\x20conditions\x20that\x20cause\x20<strong>elevated\x20ICP.</strong>\x20This\x20effect\x20helps\x20to\x20<strong>relieve\x20pressure</strong>\x20on\x20the\x20<strong>brain,</strong>\x20preventing\x20<strong>further\x20damage.</strong></p>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>The\x20other\x20diuretics\x20listed\x20Hydrochlorothiazide,\x20Spironolactone,\x20and\x20Acetazolamide\x20are\x20not\x20typically\x20used\x20for\x20managing\x20elevated\x20ICP.\x20They\x20are\x20not\x20hypertonic\x20solutes\x20and\x20thus\x20do\x20not\x20lead\x20to\x20a\x20rapid\x20reduction\x20of\x20the\x20ICP\x20as\x20mannitol\x20does.\u00a0</p>','SITGl','ZaidN','NWZlI','isArray','totalQuestions','endsWith','iGbAh','exception','closest','UKrMI','Rjixz','byeSY','XzmWT','\x20>\x20','Heparin','QAvhG','Marrow','ffpFK','rfntH','VxgoF','pop','classList','src','cWQNI','mXeaK','explanation_images','EymET','question_images','Incorrect','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','GNIAQ','vFmjW','<p>The\x20drug\x20used\x20among\x20the\x20following\x20options\x20for\x20<strong>maintenance\x20therapy</strong>\x20in\x20<strong>opium\x20addiction</strong>\x20is\x20<strong>buprenorphine.</strong></p>\x0a<p>Buprenorphine\x20is\x20a\x20<strong>partial\x20μ-opioid\x20agonist</strong>\x20and\x20an\x20<strong>antagonist</strong>\x20at\x20<strong>δ\x20</strong>and\x20<strong>κ\x20receptors</strong>.\x20It\x20is\x20widely\x20used\x20both\x20as\x20an\x20<strong>analgesic</strong>\x20for\x20<strong>chronic\x20pain\x20conditions</strong>,\x20such\x20as\x20cancer\x20pain,\x20and\x20as\x20a\x20treatment\x20for\x20<strong>opioid\x20dependence</strong>,\x20serving\x20as\x20an\x20<strong>alternative\x20</strong>to\x20<strong>methadone</strong>.</p>\x0a<p>It\x20effectively\x20<strong>controls\x20cravings</strong>\x20and<strong>\x20blocks\x20</strong>the\x20<strong>effects</strong>\x20of\x20<strong>higher-efficacy\x20opioids</strong>.\x20It\x20is\x20often\x20administered\x20in\x20<strong>combination</strong>\x20with\x20<strong>naloxone</strong>\x20to\x20<strong>prevent\x20misuse</strong>,\x20although\x20it\x20may\x20be\x20given\x20<strong>alone</strong>\x20to\x20<strong>pregnant\x20women</strong>\x20or\x20individuals\x20with\x20<strong>naloxone\x20allergies</strong>.\x20Initial\x20dosing\x20typically\x20starts\x20at\x20<strong>2-4\x20mg\x20daily</strong>,\x20with\x20adjustments\x20made\x20to\x20stabilize\x20the\x20dose\x20at\x20approximately\x20<strong>12\x20to\x2016\x20mg/day</strong>.\u00a0</p>\x0a<p>For\x20opioid\x20use\x20disorder,\x20effective\x20management\x20includes\x20both\x20<strong>withdrawal\x20</strong>and\x20<strong>long-term\x20treatment</strong>\x20strategies.\x20Withdrawal\x20and\x20detoxification\x20generally\x20start\x20with\x20<strong>managing\x20physical\x20dependence</strong>\x20using\x20medications\x20like\x20<strong>methadone\x20</strong>or\x20<strong>buprenorphine</strong>.\x20<strong>Methadone</strong>,\x20a\x20<strong>full\x20agonist</strong>,\x20is\x20used\x20to\x20stabilize\x20and\x20reduce\x20withdrawal\x20symptoms,\x20while\x20<strong>buprenorphine</strong>\x20helps\x20with\x20cravings\x20and\x20has\x20a\x20<strong>lower\x20risk</strong>\x20of\x20<strong>overdose</strong>.</p>\x0a<p><strong>Clonidine</strong>\x20and\x20<strong>lofexidine</strong>,\x20<strong>alpha-2\x20agonists,</strong>\x20are\x20used\x20to\x20<strong>ameliorate\x20withdrawal\x20symptoms</strong>.\x20Lofexidine,\x20approved\x20by\x20the\x20FDA,\x20is\x20the\x20<strong>first\x20non-opioid\x20treatment</strong>\x20specifically\x20for\x20<strong>opioid\x20withdrawal\x20</strong>in\x20adults.\x20<strong>Naltrexone</strong>,\x20a\x20long-acting\x20opioid\x20antagonist,\x20is\x20used\x20as\x20an\x20adjunct\x20in\x20patients\x20who\x20are\x20already\x20<strong>opioid-free</strong>;\x20however,\x20it\x20will\x20<strong>precipitate\x20acute\x20withdrawal\x20symptoms</strong>\x20if\x20administered\x20to\x20those\x20still\x20<strong>dependent</strong>\x20on\x20opioids.</p>','eWPlU','bookmarkedQuestions','It\x20prevents\x20overdose\x20and\x20abuse\x20of\x20Diphenoxylate','IoyYd','setItem','nav-btn-incorrect','NUBVP','duVUh','DFjOc','RcCqb','IWNNK','testModeReviewLegend','fKCvX','1|0|3|5|4|2','EMFQT','toLowerCase','RIZLN','markReviewText','A\x20patient\x20diagnosed\x20with\x20hypertriglyceridemia\x20was\x20started\x20on\x20a\x20medication,\x20following\x20which,\x20he\x20developed\x20flushing,\x20hyperglycemia,\x20and\x20elevated\x20liver\x20enzymes.\x20Identify\x20the\x20drug\x20consumed\x20by\x20the\x20patient.','efcpA','gSfAj','LBJbM','XUaDa','swAiR','strokeDasharray','PtlBs','srpml','dvnxJ','A\x20patient\x20with\x20a\x20gynecological\x20malignancy\x20is\x20started\x20on\x20Methotrexate.\x20Later\x20she\x20develops\x20oral\x20and\x20gastric\x20ulcers.\x20Which\x20nucleotide\x20synthesis\x20is\x20affected\x20in\x20her?','Amlodipine','lPYoh','status','open','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','xattb','border-red-500','YDghv','Jworc','<p>The\x20given\x20ECG\x20shows\x20<strong>pseudo\x20R\x27\x20waves</strong>:</p>','sZeHf','.m3u8','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','<p><strong>Rifampicin\x20</strong>should\x20be\x20avoided\x20as\x20it\x20is\x20a\x20potent<strong>\x20inducer\x20</strong>of<strong>\x20CYP\x20enzymes\x20</strong>including\x20CYPs\x201A2,\x203A4,\x202C9,\x20and\x202C19,\x20which\x20in\x20turn\u00a0can\x20<strong>induce\x20</strong>the<strong>\x20metabolism\x20</strong>of<strong>\x20nevirapine</strong>\x20and\x20results\x20in\x20<strong>therapeutic\x20failure\x20</strong>of\x20<strong>ART.</strong></p>\x0a<p><strong>Rifabutin\u00a0</strong>causes\x20the\x20<strong>least\x20induction</strong>\x20of\x20cytochrome\x20enzymes\x20and\x20is\x20therefore\u00a0<strong>preferred\x20in\x20HIV\x20patients</strong>\x20who\x20are\x20on<strong>\x20protease\x20inhibitors/NNRTIs.</strong></p>\x0a<p>Cytochrome\x20enzyme-inducing\x20potency\x20of\x20rifamycins\x20is\x20<strong>rifampicin\x20&gt;\x20rifapentine\x20&gt;\x20rifabutin.</strong></p>\x0a<p>Note:\u00a0</p>\x0a<table\x20style=\x22border-collapse:\x20collapse;\x20width:\x2044.9183%;\x20height:\x20255.984px;\x22\x20border=\x221\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2022.3984px;\x22>\x0a<td\x20style=\x22width:\x2020.2543%;\x20height:\x2022.3984px;\x20text-align:\x20center;\x22>Cytochrome\x20p-450\x20inducers</td>\x0a<td\x20style=\x22width:\x2079.7457%;\x20height:\x2022.3984px;\x20text-align:\x20center;\x22>Cytochrome\x20p-450\x20inhibitors</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x20233.586px;\x22>\x0a<td\x20style=\x22width:\x2020.2543%;\x20height:\x20233.586px;\x22>\x0a<ul>\x0a<li>Barbiturates</li>\x0a<li>Carbamazepine</li>\x0a<li>Rifampin</li>\x0a<li>Phenytoin</li>\x0a<li>Aminoglutethimide</li>\x0a<li>Cigarette\x20smoking</li>\x0a<li>Chronic\x20alcoholism</li>\x0a</ul>\x0a</td>\x0a<td\x20style=\x22width:\x2079.7457%;\x20height:\x20233.586px;\x22>\x0a<ul>\x0a<li>Macrolide\x20antibiotics</li>\x0a<li>Azole\x20antifungals</li>\x0a<li>Chloramphenicol</li>\x0a<li>Omeprazole</li>\x0a<li>Selective\x20serotonin\x20reuptake\x20inhibitors\x20(SSRIs)</li>\x0a<li>HIV\x20protease\x20inhibitors</li>\x0a<li>Cimetidine</li>\x0a<li>Ciprofloxacin</li>\x0a<li>Metronidazole</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','nWAWs','totalTime','XCqkq','lOpZd','green','cTacb','gnbPd','PYfpf','CTP','PKyDE','zKHUT','XnxZv','\x22\x20data-option-index=\x22','ozUaZ','get','GTGXd','bVIaV','Onkzh','kvkHI','nav-btn-marked-review','button','dlXTq','UZnQx','Spironolactone','studyModeLegend','UDP','OXMEo','study','SLwle','.option-button','VBNJu','TwukD','nav-btn-current','LteBI','Ethambutol','32suERQI','MvAKl','PADyD','SEaND','totalAttempted','glhkX','yhKxX','WtyqN','remove','cmCAC','key','Tesamorelin','kvtpu','SBAdM','location','choices','shWGm','VnliN','not-attempted','data-option-index','Synchronized\x20cardioversion\x20with\x201J\x20of\x20current','zfiZs','XMmsC','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','custom_quiz.html','timed_study','Dicyclomine','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','dfoTC','YSYxO','width','gray','HttMA','rpaMS','nav-btn-correct','Ojotv','jmFBi','Mark\x20for\x20Review','dEsjN','createElement','Which\x20of\x20the\x20following\x20reasons\x20best\x20explains\x20the\x20combination\x20of\x20Atropine\x20(0.025\x20mg)\x20and\x20Diphenoxylate\x20(2.5\x20mg)\x20for\x20treating\x20secretory\x20diarrhoea?','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','Atropine\x20potentiates\x20the\x20action\x20of\x20smooth\x20muscle\x20relaxation','nav-btn-bookmarked','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','now','Scopolamine','HZDmk','A\x20hypertensive\x20patient\x20with\x20chronic\x20kidney\x20disease\x20was\x20having\x20frequent\x20attacks\x20of\x20renal\x20colic.\x20Which\x20of\x20the\x20following\x20diuretics\x20is\x20used?','DgRUK','ArrowRight','tpfNx','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','AeWxQ','quizPerformanceData','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','EGrXc','timeDisplay','<p>The\x20<strong>volume\x20of\x20distribution</strong>\x20of\x20the\x20drug\x20<strong>determines</strong>\x20the<strong>\x20loading\x20dose</strong>\x20of\x20the\x20drug.</p>\x0a<p><strong>Loading\x20Dose</strong>\x20=\x20<strong>Volume\x20of\x20distribution</strong>\x20x\x20<strong>Desired\x20steady-state\x20plasma\x20concentration</strong>.</p>\x0a<p>When\x20the\x20time\x20to\x20reach\x20a\x20steady-state\x20is\x20long,\x20as\x20it\x20is\x20for\x20<strong>drugs</strong>\x20with\x20<strong>long\x20half-lives,</strong>\x20it\x20may\x20be\x20desirable\x20to\x20<strong>administer</strong>\x20a\x20<strong>loading\x20dose</strong>\x20that\x20promptly\x20raises\x20the\x20concentration\x20of\x20the\x20drug\x20in\x20plasma\x20to\x20the\x20target\x20concentration.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:<strong>\u00a0Clearance</strong>\x20is\x20used\x20to\x20determine\x20the\x20<strong>maintenance\x20dose</strong>.\u00a0</p>\x0a<p>Maintenance\x20dose\x20=\x20clearance\x20x\x20desired\x20steady-state\x20plasma\x20concentration.</p>\x0a<p>Options\x20C\x20and\x20D:\x20Plasma\x20<strong>half-life</strong>\x20primarily\x20<strong>determines</strong>\x20the\x20<strong>frequency</strong>\x20of\x20dosing,\x20while\x20<strong>bioavailability</strong>\x20<strong>determines</strong>\x20the\x20<strong>route</strong>\x20of\x20administration.\u00a0Though\x20bioavailability\x20may\x20affect\x20the\x20dose\x20necessary,\x20it\x20will\x20not\x20be\x20the\x20primary\x20factor\x20considered\x20during\x20the\x20calculation\x20of\x20the\x20loading\x20dose.</p>','correctCount','DOMContentLoaded','correctAnswers','back','mhzhF','hLdgf','Marked','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','kQuFw','textContent','nHYCl','contains','TUPJF','question_video','selected','KBaFW','submitSection','NkhcS','Bisoprolol','PIKPd','gJYNo','Mecasermin','35330dOLkUp','Propanolol','Are\x20you\x20sure\x20you\x20want\x20to\x20leave\x20the\x20quiz?\x20Your\x20progress\x20will\x20be\x20lost.','olngU','NGifK','text','kkWGI','Prednisolone\x20+\x20vincristine','__proto__','fXBja','yfoAs','CcImh','Adenosine\x200.1\x20mg/kg','totalTimeResult','DNlNm','mkToX','<p>The\x20drug\x20most\x20likely\x20responsible\x20for\x20causing\x20<strong>flushing,\x20hyperglycemia,</strong>\x20and\x20elevated\x20liver\x20enzymes\x20in\x20a\x20patient\x20being\x20treated\x20for\x20<strong>hypertriglyceridemia</strong>\x20is\x20<strong>Nicotinamide</strong>\x20(Niacin).\u00a0</p>\x0a<p>Niacin\x20(nicotinic\x20acid),\x20is\x20commonly\x20used\x20to\x20treat\x20hypertriglyceridemia\x20and\x20hypercholesterolemia.\x20However,\x20it\x20is\x20associated\x20with\x20side\x20effects\x20such\x20as\x20<strong>flushing,</strong>\x20which\x20is\x20due\x20to\x20<strong>prostaglandin-mediated\x20vasodilation.</strong>\x20Niacin\x20can\x20also\x20lead\x20to\x20<strong>hyperglycemia</strong>\x20by\x20<strong>impairing\x20insulin\x20sensitivity</strong>\x20and\x20may\x20cause\x20<strong>elevated\x20liver\x20enzymes,</strong>\x20indicating\x20<strong>potential\x20hepatotoxicity.</strong>\u00a0</p>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>Option\x20B:\x20<strong>Rosuvastatin</strong>\x20is\x20a\x20statin,\x20primarily\x20used\x20to\x20lower\x20<strong>LDL</strong>\x20cholesterol,\x20and\x20while\x20it\x20may\x20elevate\x20liver\x20enzymes,\x20it\x20is\x20less\x20commonly\x20associated\x20with\x20flushing\x20and\x20hyperglycemia.\x20It\x20can\x20cause\x20<strong>myopathy</strong>\x20in\x20patients.\u00a0</p>\x0a<p>Option\x20C:\x20<strong>Ezetimibe</strong>\x20inhibits\x20<strong>cholesterol\x20absorption</strong>\x20in\x20the\x20intestines\x20and\x20is\x20not\x20typically\x20associated\x20with\x20these\x20side\x20effects.</p>\x0a<p>Option\x20D:\x20<strong>Fenofibrate</strong>\x20is\x20used\x20to\x20lower\x20<strong>triglycerides</strong>\x20can\x20elevate\x20<strong>liver\x20enzymes</strong>\x20and\x20can\x20increase\x20the\x20risk\x20of\x20developing\x20myopathy\x20if\x20used\x20concomitantly\x20with\x20statins,\x20but\x20it\x20does\x20not\x20commonly\x20cause\x20flushing\x20or\x20hyperglycemia.</p>','rsFzX','round','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','A\x20hypertensive\x20patient\x20is\x20started\x20on\x20a\x20drug\x20to\x20control\x20his\x20BP.\x20He\x20had\x20complaints\x20of\x20dry\x20mouth,\x20drowsiness,\x20and\x20confusion\x20after\x20taking\x20this\x20drug,\x20but\x20he\x20still\x20continued\x20to\x20take\x20the\x20drug\x20for\x201\x20year.\x20He\x20had\x20to\x20travel\x20abroad\x20for\x20work,\x20and\x20he\x20forgot\x20to\x20take\x20his\x20medications.\x20He\x20now\x20presents\x20with\x20a\x20blood\x20pressure\x20of\x20200/120mmHg.\x20Identify\x20the\x20drug\x20he\x20was\x20on?','progressBar','PdRDD','constructor','floor','eqdhV','The\x20occurence\x20of\x20oral\x20candidiasis\x20is\x20more\x20compared\x20to\x20other\x20inhaled\x20steroids','Zgfmr','YlZXf','fcBcx','zJfuZ','CJDZB','xgcRD','In\x20which\x20phase\x20of\x20clinical\x20trials\x20is\x20drug\x20dosing\x20done?','name','removeItem','Ipratropium','reviewQuestionsContainer','<p>The\x20drug\x20marked\x20as\x20\x27X\x27\x20in\x20the\x20image\x20is\x20<strong>aminocaproic\x20acid.</strong></p>\x0a<p><strong>ε-Aminocaproic\x20acid</strong>,\x20a\x20<strong>lysine\x20analogue</strong>\x20that\x20competes\x20with\x20<strong>plasminogen</strong>\x20for\x20<strong>binding\x20sites</strong>\x20on\x20<strong>fibrin</strong>.\x20By\x20blocking\x20this\x20interaction,\x20ε-Aminocaproic\x20acid\x20<strong>prevents</strong>\x20the\x20conversion\x20of\x20<strong>plasminogen</strong>\x20into\x20<strong>plasmin</strong>,\x20thereby\x20<strong>inhibiting\x20fibrinolysis</strong>.\x20This\x20action\x20makes\x20it\x20a\x20useful\x20agent\x20for\x20<strong>reversing</strong>\x20the\x20effects\x20of\x20<strong>fibrinolytic\x20therapy</strong>.</p>\x0a<p>However,\x20ε-Aminocaproic\x20acid\x20should\x20be\x20administered\x20with\x20caution\x20as\x20it\x20can\x20<strong>suppress\x20intrinsic\x20fibrinolytic\x20activity</strong>,\x20potentially\x20leading\x20to\x20complications\x20such\x20as\x20<strong>disseminated\x20intravascular\x20coagulation\x20(DIC)</strong>.\x20To\x20address\x20this,\x20<strong>fresh\x20frozen\x20plasma</strong>\x20and\x20<strong>cryoprecipitate</strong>\x20may\x20be\x20used\x20to\x20restore\x20fibrin\x20and\x20clotting\x20factors.</p>','red','OTkMN','Clonidine','oLMVM','forEach','fromCharCode','target','LqaNr','Tenecteplase','accuracyScore','GXAhT','thcwA','qhLsQ','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','OJUoM','sIoEd','jRQLL','qixJl','It\x20is\x20a\x20prodrug\x20metabolised\x20by\x20bronchial\x20esterase','armFu','uabom','kvnYj','CDgvR','Atropine\x20increases\x20the\x20antimotility\x20action\x20of\x20diphenoxylate','Not\x20Attempted','cwOzY','Loratidine','BMRLJ','timed_exam','padStart','phNcf','CYznG','FGtWs','razui','https://dhmbxeygs57ff.cloudfront.net/uploads/2d4980e7ca344abdb4c864c7546e97d0x1280x1845.JPEG','https://dhmbxeygs57ff.cloudfront.net/uploads/d3d48754732b440fb17b875d2b52a8dax510x812.PNG','wfUuC','kOZMT','yxNPs','uUnLc','Which\x20of\x20the\x20following\x20drugs\x20when\x20added\x20with\x20erythromycin\x20can\x20lead\x20to\x20torsades\x20de\x20pointes?','Identify\x20the\x20drug\x20marked\x20as\x20\x27X\x27\x20in\x20the\x20image.','Fenofibrate','incorrectAnswers','jaKdY','WBBHu','https://dhmbxeygs57ff.cloudfront.net/uploads/d865b671317e4be1a17a74242c10f2d4x1280x1905.JPEG','includes','div','<div\x20class=\x22mt-4\x22><img\x20src=\x22','border-green-500','oIYdy','OJrmY','https://dhmbxeygs57ff.cloudfront.net/uploads/a1052845f6b14466b77a39d656743628x1280x1194.JPEG','QZorG','Octreotide','length','EfcGu','Option\x20','uTpmu','IVIG','RhrHS','egqqT','flex','attachMedia','kNzTh','<p>The\x20given\x20clinical\x20scenario\x20suggests\x20a\x20diagnosis\x20of\x20<strong>Acute\x20Lymphoblastic\x20Leukemia\x20</strong>(ALL),\x20and\x20standard\x20initial\x20treatment\x20in\x20children\x20includes\x20a\x20chemotherapy\x20regimen\x20with\x20drugs\x20like\x20<strong>prednisolone</strong>\x20and\x20<strong>vincristine</strong>\x20during\x20the<strong>\x20induction\x20phase</strong>.\u00a0</p>\x0a<p>Patients\x20diagnosed\x20with\x20ALL\x20present\x20with\x20symptoms\x20of<strong>\x20impaired\x20marrow\x20function</strong>\x20like\x20<strong>anaemia,\x20infections</strong>\x20secondary\x20to\x20neutropenia,\x20and\x20<strong>bleeding</strong>\x20due\x20to\x20thrombocytopenia.\x20Other\x20symptoms\x20include\x20<strong>bone\x20pain</strong>,\x20generalized\x20lymphadenopathy,\x20splenomegaly,\x20hepatomegaly,\x20testicular\x20enlargement,\x20headache,\x20vomiting,\x20and\x20nerve\x20palsies.</p>\x0a<p>Treatment\x20of\x20ALL</p>\x0a<p><strong>Induction:</strong>\x20L-Asparaginase,\x20vincristine,\x20prednisolone,\x20and\x20anthracycline<br\x20/><strong>CNS\x20prophylaxis\x20</strong>with\x20intrathecal\x20methotrexate<br\x20/><strong>Consolidation:</strong>\x20Methotrexate,\x20cytarabine\u00a0<br\x20/><strong>Maintenance:</strong>\x206-Mercaptopurine,\x20methotrexate\x20plus\x20intrathecal\x20therapy</p>\x0a<p>Other\x20Options:</p>\x0a<p>Option\x20A:\x20IVIG:\x20Intravenous\x20immunoglobulin\x20(IVIG)\x20is\x20<strong>not</strong>\x20used\x20for\x20treating\x20ALL.</p>\x0a<p>option\x20B:\x20Both\x20<strong>doxorubicin</strong>\x20and\x20<strong>idarubicin</strong>\x20<strong>are</strong>\x20<strong>anthracyclines</strong>\x20used\x20in\x20chemotherapy.\x20While\x20doxorubicin\x20can\x20be\x20part\x20of\x20certain\x20ALL\x20treatment\x20protocols,\x20idarubicin\x20is\x20more\x20commonly\x20used\x20in\x20Acute\x20Myeloid\x20Leukemia\x20(AML)\x20rather\x20than\x20ALL.\x20This\x20combination\x20is\x20not\x20typically\x20used\x20in\x20the\x20induction\x20phase\x20for\x20ALL\x20children.</p>\x0a<p>Option\x20D:\x20Radiotherapy\x20is\x20<strong>not</strong>\x20a\x20standard\x20initial\x20treatment\x20for\x20ALL.\x20It\x20may\x20be\x20considered\x20in\x20specific\x20cases,\x20such\x20as\x20central\x20nervous\x20system\x20involvement\x20or\x20certain\x20high-risk\x20cases,\x20but\x20the\x20primary\x20treatment\x20for\x20ALL\x20is\x20systemic\x20chemotherapy,\x20not\x20localized\x20radiotherapy.</p>','info','FtDFX','Tolterodine','1459830rHdsBA','markReviewBtn','fXpsk','https://dhmbxeygs57ff.cloudfront.net/uploads/61107bbff6054604a20f8b083695fb2dx1279x685.JPEG','1271880YxcNLc','rXWzs','Bookmarked','TiGef','navBtn_'];_0x14a2=function(){return _0x4c5726;};return _0x14a2();}function initializeQuiz(){const _0x3e4b03=_0x2a1f1a,_0x299e44={'IvuQt':_0x3e4b03(0x2ed),'QNgSd':_0x3e4b03(0x1ee),'RKOXE':function(_0x3a6fc4,_0x52edf7){return _0x3a6fc4===_0x52edf7;},'VnliN':_0x3e4b03(0x163),'dlXTq':_0x3e4b03(0x29f),'razui':'block','osiUy':_0x3e4b03(0xc4),'kNzTh':'none','YbJLu':_0x3e4b03(0x1b2),'raQgL':_0x3e4b03(0x11a),'TUPJF':_0x3e4b03(0x186),'kkWGI':_0x3e4b03(0xe8),'jcroK':_0x3e4b03(0x1ed),'LLUBW':function(_0x5b57f5){return _0x5b57f5();}};quizStartTime=Date[_0x3e4b03(0xfc)]();const _0x46b47a=document[_0x3e4b03(0x284)](_0x299e44['IvuQt']),_0x26b9da=document['getElementById'](_0x3e4b03(0x18e)),_0x296c43=document[_0x3e4b03(0x284)](_0x3e4b03(0x336)),_0x2736c5=currentMode===_0x299e44[_0x3e4b03(0x243)]||_0x299e44[_0x3e4b03(0x1a1)](currentMode,_0x299e44[_0x3e4b03(0xe0)]);document[_0x3e4b03(0x284)](_0x299e44[_0x3e4b03(0xc1)])['style'][_0x3e4b03(0x2b1)]=_0x2736c5?_0x3e4b03(0x256):_0x299e44['razui'],document[_0x3e4b03(0x284)](_0x299e44[_0x3e4b03(0x2d6)])[_0x3e4b03(0x2a1)][_0x3e4b03(0x2b1)]=_0x2736c5?_0x299e44[_0x3e4b03(0x188)]:_0x299e44[_0x3e4b03(0x168)],document[_0x3e4b03(0x284)](_0x299e44[_0x3e4b03(0x25b)])[_0x3e4b03(0x2a1)][_0x3e4b03(0x2b1)]=_0x2736c5?'block':_0x299e44[_0x3e4b03(0x188)],document[_0x3e4b03(0x284)](_0x299e44[_0x3e4b03(0x2eb)])[_0x3e4b03(0x2a1)][_0x3e4b03(0x2b1)]=_0x2736c5?_0x299e44[_0x3e4b03(0x168)]:_0x299e44['kNzTh'],_0x46b47a[_0x3e4b03(0x2a1)][_0x3e4b03(0x2b1)]=_0x2736c5?_0x299e44[_0x3e4b03(0x188)]:_0x299e44[_0x3e4b03(0x116)],_0x26b9da[_0x3e4b03(0x2a1)][_0x3e4b03(0x2b1)]=_0x2736c5?_0x299e44[_0x3e4b03(0x116)]:_0x299e44[_0x3e4b03(0x188)],_0x296c43[_0x3e4b03(0x2a1)][_0x3e4b03(0x2b1)]=_0x2736c5?_0x299e44[_0x3e4b03(0x116)]:_0x299e44[_0x3e4b03(0x188)],(_0x299e44['RKOXE'](currentMode,_0x299e44[_0x3e4b03(0x126)])||currentMode===_0x3e4b03(0x163))&&document[_0x3e4b03(0x284)](_0x3e4b03(0x207))[_0x3e4b03(0x31f)][_0x3e4b03(0xd7)](_0x299e44[_0x3e4b03(0x21e)]),_0x299e44['LLUBW'](loadBookmarkedQuestions),generateQuestionNav(),_0x299e44[_0x3e4b03(0x26d)](updateStats),displayQuestion();}function generateQuestionNav(){const _0x525d35=_0x2a1f1a,_0x44196f={'CYznG':_0x525d35(0x274),'LdvuT':function(_0x53c16b,_0x1d182a){return _0x53c16b<_0x1d182a;},'cWQNI':function(_0x804c57,_0x1ffe5e){return _0x804c57!==_0x1ffe5e;},'DFjOc':_0x525d35(0x1bb),'cTacb':_0x525d35(0xc0),'aePfy':function(_0x2dbe17,_0x35d8df){return _0x2dbe17+_0x35d8df;},'fAqMD':function(_0x54e09c){return _0x54e09c();}},_0x54a330=document[_0x525d35(0x284)](_0x44196f[_0x525d35(0x166)]);_0x54a330[_0x525d35(0x262)]='';for(let _0x4422ec=0x0;_0x44196f['LdvuT'](_0x4422ec,questionsData[_0x525d35(0x17f)]);_0x4422ec++){if(_0x44196f[_0x525d35(0x321)](_0x525d35(0x1bb),_0x44196f[_0x525d35(0x333)])){if(_0x5b804d[_0x525d35(0x1e2)]()){const _0x414e68=new _0x2efa5c();_0x414e68[_0x525d35(0x203)](_0x5d275d),_0x414e68[_0x525d35(0x187)](_0x5a0d62);}else _0x5cb03f[_0x525d35(0x29c)](_0x525d35(0x2b0))&&(_0xe1e4f['src']=_0x1f7903);}else{const _0x3d1ffc=document[_0x525d35(0xf6)](_0x44196f[_0x525d35(0xb1)]);_0x3d1ffc[_0x525d35(0x113)]=_0x44196f[_0x525d35(0x22a)](_0x4422ec,0x1),_0x3d1ffc['className']=_0x525d35(0x2c1),_0x3d1ffc['onclick']=()=>jumpToQuestion(_0x4422ec),_0x3d1ffc['id']=_0x525d35(0x195)+_0x4422ec,_0x54a330['appendChild'](_0x3d1ffc);}}_0x44196f['fAqMD'](updateQuestionNav);}function updateQuestionNav(){const _0x25d669=_0x2a1f1a,_0x53ec6a={'IjRKs':function(_0xa91ddf,_0x41fb80){return _0xa91ddf===_0x41fb80;},'RxrSj':_0x25d669(0x177),'upTcE':function(_0x3061f1,_0x5b1c4e){return _0x3061f1+_0x5b1c4e;},'HAVNx':_0x25d669(0x181),'NrIZc':function(_0x53408c,_0x214135){return _0x53408c(_0x214135);},'Bvlkh':'data-option-index','aCqtB':_0x25d669(0x2fc),'SOATq':function(_0x3d9563,_0x5cdb1e){return _0x3d9563!==_0x5cdb1e;},'PYfpf':_0x25d669(0x2d9),'aSuTU':function(_0x4503b3,_0x2966c0){return _0x4503b3===_0x2966c0;},'PtafS':_0x25d669(0xcc),'giKdI':_0x25d669(0xb2),'whKnG':_0x25d669(0xfa),'eqdhV':_0x25d669(0x28d),'nqBse':_0x25d669(0xbf),'nZKVl':function(_0xc29c33,_0xd1fea6){return _0xc29c33===_0xd1fea6;},'vekgT':'study','IKvEh':function(_0x4c213a,_0x410400){return _0x4c213a===_0x410400;},'azGbk':_0x25d669(0xe8),'dfoTC':'apwjr','zfiZs':function(_0x164441,_0x3c8371){return _0x164441===_0x3c8371;},'wWqGO':'correct','jmFBi':_0x25d669(0xf1),'OXMEo':_0x25d669(0xe6),'WBBHu':_0x25d669(0x2bb),'lkCaY':'nav-btn-answered'};for(let _0x21ca60=0x0;_0x21ca60<questionsData[_0x25d669(0x17f)];_0x21ca60++){if(_0x53ec6a[_0x25d669(0x1b1)](_0x53ec6a[_0x25d669(0xb3)],_0x25d669(0x2d9))){const _0x5d3dab={'yTSVj':function(_0x1f8e6a,_0x4ded15){const _0x500fa8=_0x25d669;return _0x53ec6a[_0x500fa8(0x20e)](_0x1f8e6a,_0x4ded15);},'Zgfmr':_0x53ec6a['Bvlkh'],'kvtpu':function(_0x24c50f,_0x346ba2){const _0x5f4fab=_0x25d669;return _0x53ec6a[_0x5f4fab(0x20e)](_0x24c50f,_0x346ba2);}};_0x43a589[_0x25d669(0xde)][_0x25d669(0x14b)]((_0x1ceff4,_0x1ec215)=>{const _0x5b28ed=_0x25d669,_0x12fac6=_0x3255df[_0x5b28ed(0x14c)](0x41+_0x1ec215),_0x53d579=_0x53ec6a[_0x5b28ed(0x210)](_0x582483,_0x1ec215),_0x33d0d3=_0xfc6427['createElement'](_0x53ec6a['RxrSj']);_0x33d0d3[_0x5b28ed(0x262)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x53d579?_0x5b28ed(0x118):'')+_0x5b28ed(0xb8)+_0x1ec215+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x12fac6+_0x5b28ed(0xea)+(_0x1ceff4[_0x5b28ed(0x125)]||_0x53ec6a[_0x5b28ed(0x21a)](_0x53ec6a[_0x5b28ed(0x248)],_0x53ec6a[_0x5b28ed(0x21a)](_0x1ec215,0x1)))+_0x5b28ed(0x197),_0x28a1f6['appendChild'](_0x33d0d3);}),_0x3550c4[_0x25d669(0x289)](_0x53ec6a[_0x25d669(0x302)],function(_0x1de268){const _0x359c9a=_0x25d669,_0x4e0d8d=_0x1de268[_0x359c9a(0x14d)]['closest'](_0x359c9a(0xc9));if(_0x4e0d8d){const _0x565d06=_0x5d3dab['yTSVj'](_0x3a7f2a,_0x4e0d8d[_0x359c9a(0x1ef)](_0x5d3dab[_0x359c9a(0x13b)]));_0x5d3dab[_0x359c9a(0xdb)](_0x39ad2a,_0x565d06);}});}else{const _0x44d89a=document[_0x25d669(0x284)](_0x25d669(0x195)+_0x21ca60),_0x9322ca=questionStates[_0x21ca60];let _0x174955='';if(_0x53ec6a[_0x25d669(0x2fb)](_0x21ca60,currentQuestionIndex))_0x174955=_0x53ec6a['PtafS'];else{if(_0x9322ca[_0x25d669(0x1c3)])_0x53ec6a[_0x25d669(0x2fb)](_0x53ec6a['giKdI'],_0x25d669(0x196))?_0x5c4e6b[_0x25d669(0x1f7)]<_0x15dd2c[_0x25d669(0x17f)]&&(_0x5cb6b5[_0x560e03[_0x25d669(0x1f7)]]['bookmarked']=!![]):_0x174955=_0x53ec6a['whKnG'];else{if(_0x9322ca[_0x25d669(0x225)]){if(_0x53ec6a[_0x25d669(0x139)]!==_0x53ec6a[_0x25d669(0x139)]){const _0x4a4466=new _0x4b8eaf();_0x4a4466[_0x25d669(0x203)](_0x1f765a),_0x4a4466[_0x25d669(0x187)](_0x3cf6b9);}else _0x174955=_0x53ec6a['nqBse'];}else{if(_0x53ec6a[_0x25d669(0x22f)](currentMode,_0x53ec6a['vekgT'])||_0x53ec6a['IKvEh'](currentMode,_0x53ec6a[_0x25d669(0x1a9)])){if(_0x53ec6a[_0x25d669(0x1b1)](_0x53ec6a[_0x25d669(0xeb)],_0x53ec6a[_0x25d669(0xeb)]))_0x148e99[_0x25d669(0x2f7)]('video[data-src]')[_0x25d669(0x14b)](_0x4577b1=>{const _0x3059ff=_0x25d669,_0x4af95d=_0x4577b1[_0x3059ff(0x2ba)]['src'];if(_0x4af95d&&_0x4af95d[_0x3059ff(0x176)]('.m3u8'))_0x2ef045(_0x4577b1,_0x4af95d);else _0x4af95d&&(_0x4577b1[_0x3059ff(0x320)]=_0x4af95d);});else{if(_0x53ec6a[_0x25d669(0xe4)](_0x9322ca['status'],_0x53ec6a[_0x25d669(0x1b9)]))_0x174955=_0x53ec6a[_0x25d669(0xf3)];else{if(_0x53ec6a['IKvEh'](_0x9322ca['status'],_0x25d669(0x2da)))_0x174955=_0x25d669(0x330);else _0x174955=_0x53ec6a[_0x25d669(0xc6)];}}}else{if(_0x53ec6a[_0x25d669(0x1b1)](_0x53ec6a['WBBHu'],_0x53ec6a[_0x25d669(0x174)]))_0x3a6749=_0x3ae89a;else{if(_0x9322ca[_0x25d669(0x222)]!==null)_0x174955=_0x53ec6a['lkCaY'];else _0x174955=_0x53ec6a['OXMEo'];}}}}}_0x44d89a[_0x25d669(0x298)]=_0x25d669(0xa2)+_0x174955;}}}function jumpToQuestion(_0x528b3e){const _0x3af506=_0x2a1f1a,_0x5b0f2c={'JVLra':_0x3af506(0xc9),'yfoAs':function(_0x2a1d60,_0x44db20){return _0x2a1d60(_0x44db20);},'WtyqN':function(_0x1290bd,_0x21d875){return _0x1290bd!==_0x21d875;},'sVmSM':function(_0x5ecda9,_0x4e0de3){return _0x5ecda9-_0x4e0de3;},'OJrmY':function(_0x262b7e){return _0x262b7e();}};if(_0x528b3e>=0x0&&_0x528b3e<questionsData[_0x3af506(0x17f)]){if(questionStartTime){if(_0x5b0f2c[_0x3af506(0xd6)](_0x3af506(0x215),_0x3af506(0x215))){const _0x3e1acb=_0x3bed4b[_0x3af506(0x14d)]['closest'](_0x5b0f2c['JVLra']);if(_0x3e1acb){const _0x1b8b34=_0x1d8586(_0x3e1acb[_0x3af506(0x1ef)](_0x3af506(0xe2)));_0x5b0f2c[_0x3af506(0x12a)](_0x337e98,_0x1b8b34);}}else questionStates[currentQuestionIndex][_0x3af506(0x1d8)]+=_0x5b0f2c['sVmSM'](Date['now'](),questionStartTime);}currentQuestionIndex=_0x528b3e,_0x5b0f2c[_0x3af506(0x17b)](displayQuestion);}}function updateStats(){const _0x329047=_0x2a1f1a,_0x5dc875={'rfntH':function(_0x129925,_0x55bef0){return _0x129925===_0x55bef0;},'PdRDD':_0x329047(0xc7),'lNnvv':_0x329047(0xe8),'lnlyQ':_0x329047(0x10a),'JmSUG':_0x329047(0x238),'cKVXA':'totalAttempted','bRvMX':function(_0x5bb1ca,_0x2f8c36){return _0x5bb1ca/_0x2f8c36;},'sCoZZ':_0x329047(0x292),'fcBcx':function(_0x24ae61,_0x20974e){return _0x24ae61+_0x20974e;},'fKCvX':_0x329047(0x1d8)};if(_0x5dc875[_0x329047(0x31c)](currentMode,_0x5dc875[_0x329047(0x136)])||currentMode===_0x5dc875['lNnvv']){document[_0x329047(0x284)](_0x5dc875[_0x329047(0x26f)])[_0x329047(0x113)]=stats[_0x329047(0x10c)],document[_0x329047(0x284)](_0x5dc875[_0x329047(0x22c)])['textContent']=stats[_0x329047(0x172)],document['getElementById'](_0x5dc875[_0x329047(0x1a2)])[_0x329047(0x113)]=stats['totalAttempted'];const _0x1cd0d6=stats[_0x329047(0xd3)]>0x0?Math[_0x329047(0x132)](_0x5dc875[_0x329047(0x27b)](stats[_0x329047(0x10c)],stats[_0x329047(0xd3)])*0x64):0x0;document['getElementById'](_0x5dc875[_0x329047(0x19d)])[_0x329047(0x113)]=_0x5dc875['fcBcx'](_0x1cd0d6,'%'),stats[_0x329047(0xad)]=questionStates[_0x329047(0x279)]((_0x579ef0,_0x5566ec)=>_0x579ef0+_0x5566ec['timeSpent'],0x0);const _0x5ce173=Math[_0x329047(0x138)](_0x5dc875[_0x329047(0x27b)](stats[_0x329047(0xad)],0x3e8)),_0x1dcddd=Math[_0x329047(0x138)](_0x5dc875[_0x329047(0x27b)](_0x5ce173,0x3c)),_0x227625=_0x5ce173%0x3c;document['getElementById'](_0x5dc875[_0x329047(0x337)])[_0x329047(0x113)]=_0x5dc875[_0x329047(0x13d)](_0x1dcddd+':',_0x227625['toString']()[_0x329047(0x164)](0x2,'0'));}}function setupVideo(_0x47c0be,_0x4eb2f4){const _0x439ea2=_0x2a1f1a,_0x19eadd={'kRRGh':function(_0x390829){return _0x390829();},'IDUJI':_0x439ea2(0x2b0),'OheIH':function(_0x259012,_0x496914){return _0x259012!==_0x496914;},'FHGpA':'bTsuW','VBNJu':'AImPJ'};if(Hls[_0x439ea2(0x1e2)]()){const _0xccc098=new Hls();_0xccc098['loadSource'](_0x4eb2f4),_0xccc098['attachMedia'](_0x47c0be);}else _0x47c0be[_0x439ea2(0x29c)](_0x19eadd[_0x439ea2(0x239)])&&(_0x19eadd['OheIH'](_0x19eadd[_0x439ea2(0x282)],_0x19eadd[_0x439ea2(0xca)])?_0x47c0be['src']=_0x4eb2f4:(_0x15579b++,_0x19eadd['kRRGh'](_0xe26436)));}function displayQuestion(){const _0x5b682a=_0x2a1f1a,_0x547455={'IXboP':function(_0x16b3aa,_0x42f4af){return _0x16b3aa===_0x42f4af;},'QvWRb':function(_0x300f3e,_0x2f12ef){return _0x300f3e===_0x2f12ef;},'KKbxc':'border-gray-600','LlaxV':_0x5b682a(0xa4),'GNIAQ':_0x5b682a(0x2ed),'tEfuD':_0x5b682a(0x263),'Ofajw':_0x5b682a(0x2e4),'qixJl':_0x5b682a(0x1d0),'SITGl':_0x5b682a(0x1f5),'biqqX':function(_0x41884e,_0xd03968){return _0x41884e!==_0xd03968;},'GTGXd':_0x5b682a(0x129),'FtDFX':function(_0x23ba9e,_0x4d6fec){return _0x23ba9e+_0x4d6fec;},'AJHzQ':_0x5b682a(0x118),'pXxqe':_0x5b682a(0x181),'EymET':'2|5|0|1|4|3','jaKdY':_0x5b682a(0x22e),'MxLWJ':'quizHierarchy','OVJJt':'\x20>\x20','MVCfZ':_0x5b682a(0x24e),'uPPDG':_0x5b682a(0x23f),'iijkE':_0x5b682a(0xc9),'guOYS':_0x5b682a(0x303),'vlrTc':function(_0x14286d,_0x1fe631){return _0x14286d(_0x1fe631);},'bVIaV':function(_0x23dd4f,_0x3bf368){return _0x23dd4f===_0x3bf368;},'BZHAO':_0x5b682a(0x329),'qunNU':_0x5b682a(0x15b),'zJfuZ':_0x5b682a(0x1e3),'LqaNr':_0x5b682a(0x2ce),'fBMwc':_0x5b682a(0x135),'FDXJu':function(_0x219a28){return _0x219a28();},'rXWzs':_0x5b682a(0x2fa),'swAiR':_0x5b682a(0x1ed),'IsfuV':'No\x20question\x20text\x20available','rJjOR':_0x5b682a(0x2b3),'TwukD':'oQPVJ','hPylo':_0x5b682a(0x20d),'gTJsD':'click','Jfnix':_0x5b682a(0xe8),'kvkHI':function(_0x15808b,_0xf5acf4){return _0x15808b===_0xf5acf4;},'rpaMS':_0x5b682a(0x163)};if(!questionsData||questionsData[_0x5b682a(0x17f)]===0x0){if(_0x547455[_0x5b682a(0xbc)](_0x547455['BZHAO'],_0x547455[_0x5b682a(0x270)])){const _0x174d49=_0x547455[_0x5b682a(0x1a8)](_0x1f2073[_0x5b682a(0x222)],_0x27bdf8),_0x462ff7=_0x547455[_0x5b682a(0x1ff)](_0x18300f['id'],_0x5a04eb);let _0x5b0d07=_0x547455[_0x5b682a(0x2c9)];if(_0x462ff7)_0x5b0d07=_0x5b682a(0x179);else{if(_0x174d49)_0x5b0d07=_0x547455[_0x5b682a(0x19e)];}return _0x5b682a(0x133)+_0x5b0d07+_0x5b682a(0xf8)+_0x59a21a[_0x5b682a(0x14c)](0x41+_0x3a9886)+_0x5b682a(0x1b0)+_0x2cbcf5['text']+_0x5b682a(0x1c0);}else{document[_0x5b682a(0x284)](_0x547455[_0x5b682a(0x13e)])[_0x5b682a(0x262)]=_0x547455[_0x5b682a(0x14e)];return;}};const _0x2fc370=questionsData[currentQuestionIndex];questionStartTime=Date[_0x5b682a(0xfc)](),selectedOption=questionStates[currentQuestionIndex][_0x5b682a(0x222)];const _0x47892b=_0x547455[_0x5b682a(0x18b)](currentQuestionIndex,0x1)/questionsData['length']*0x64;document[_0x5b682a(0x284)](_0x547455[_0x5b682a(0x275)])[_0x5b682a(0x2a1)][_0x5b682a(0xed)]=_0x47892b+'%',document[_0x5b682a(0x284)]('currentQuestion')[_0x5b682a(0x113)]=_0x547455[_0x5b682a(0x18b)](currentQuestionIndex,0x1),_0x547455[_0x5b682a(0x1cf)](updateQuestionNav),document[_0x5b682a(0x284)]('prevBtn')[_0x5b682a(0x2e5)]=currentQuestionIndex===0x0,document[_0x5b682a(0x284)](_0x547455[_0x5b682a(0x192)])[_0x5b682a(0x31f)]['add'](_0x547455[_0x5b682a(0x98)]),document[_0x5b682a(0x284)](_0x547455[_0x5b682a(0x13e)])[_0x5b682a(0x262)]=_0x2fc370['text']||_0x547455['IsfuV'];let _0x2e5fe1='';if(_0x2fc370['question_audio'])_0x2e5fe1+=_0x5b682a(0x2a4)+_0x2fc370[_0x5b682a(0x25a)]+_0x5b682a(0x21d);if(_0x2fc370[_0x5b682a(0x117)])_0x2e5fe1+=_0x5b682a(0x103)+_0x2fc370['question_video']+_0x5b682a(0x1e5);_0x2fc370[_0x5b682a(0x325)]&&_0x2fc370['question_images'][_0x5b682a(0x14b)](_0x448101=>{const _0x225eb3=_0x5b682a;if(_0x448101)_0x2e5fe1+=_0x225eb3(0x154)+_0x448101+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';});document[_0x5b682a(0x284)](_0x5b682a(0x1a4))[_0x5b682a(0x262)]=_0x2e5fe1;const _0x390a1b=document['getElementById'](_0x547455[_0x5b682a(0x2e8)]);_0x390a1b[_0x5b682a(0x262)]='',_0x390a1b[_0x5b682a(0x31f)]['remove']('answered');if(_0x2fc370[_0x5b682a(0xde)]&&Array[_0x5b682a(0x30d)](_0x2fc370['choices'])){if(_0x547455[_0x5b682a(0xcb)]===_0x547455['hPylo']){const _0x85e248=_0x1c7ca3[_0x5b682a(0x284)](_0x547455[_0x5b682a(0x328)]),_0x3d4c5a=_0x3b2eea[_0x5b682a(0x284)](_0x547455[_0x5b682a(0x27d)]),_0x18fcce=_0x47b46c[_0x30fa0a][_0x5b682a(0x1c3)];_0x85e248[_0x5b682a(0x298)]=_0x18fcce?_0x547455[_0x5b682a(0x2af)]:_0x547455[_0x5b682a(0x158)],_0x3d4c5a[_0x5b682a(0x113)]=_0x18fcce?_0x5b682a(0x193):_0x547455[_0x5b682a(0x30a)];}else _0x2fc370['choices'][_0x5b682a(0x14b)]((_0x27a84f,_0x39e065)=>{const _0x383882=_0x5b682a;if(_0x547455[_0x383882(0x25c)](_0x383882(0x119),_0x547455[_0x383882(0xbb)])){const _0x35041a=String['fromCharCode'](_0x547455[_0x383882(0x18b)](0x41,_0x39e065)),_0x4749a6=_0x547455[_0x383882(0x1a8)](selectedOption,_0x39e065),_0x3f4e44=document[_0x383882(0xf6)]('div');_0x3f4e44['innerHTML']=_0x383882(0x1f0)+(_0x4749a6?_0x547455[_0x383882(0x1dc)]:'')+_0x383882(0xb8)+_0x39e065+_0x383882(0x25f)+_0x35041a+_0x383882(0xea)+(_0x27a84f['text']||_0x547455[_0x383882(0x18b)](_0x547455[_0x383882(0x1fc)],_0x39e065+0x1))+_0x383882(0x197),_0x390a1b['appendChild'](_0x3f4e44);}else _0x1d6718=_0x5e2c92[_0x383882(0x2e0)](_0xe3794a=>!(_0xe3794a[_0x383882(0x228)]['includes'](_0x45f238[_0x383882(0x33a)]()[_0x383882(0x307)](/ /g,'-'))&&_0xe3794a[_0x383882(0x1f7)]===_0x1896ac));}),_0x390a1b[_0x5b682a(0x289)](_0x547455['gTJsD'],function(_0x14919b){const _0x422aaf=_0x5b682a;if(_0x547455[_0x422aaf(0x2ee)]!==_0x422aaf(0x23f)){const _0x3bc514=_0x547455[_0x422aaf(0x324)][_0x422aaf(0x2f1)]('|');let _0x31be5c=0x0;while(!![]){switch(_0x3bc514[_0x31be5c++]){case'0':_0x315392=_0x3efc63['hierarchy'];continue;case'1':_0x1cda23[_0x422aaf(0x245)]=_0x547455[_0x422aaf(0x18b)](_0x1bf4cb,_0x547455[_0x422aaf(0x173)]);continue;case'2':_0x3ba302=_0x130558['questions'];continue;case'3':_0x17864d[_0x422aaf(0x284)](_0x547455['MxLWJ'])[_0x422aaf(0x113)]=_0x249194[_0x422aaf(0x2e9)](_0x547455['OVJJt']);continue;case'4':_0x496ec2[_0x422aaf(0x284)](_0x422aaf(0x30e))[_0x422aaf(0x113)]=_0x43ca5a['length'];continue;case'5':_0x2078b8=_0xc2ed5d[_0x422aaf(0x142)];continue;}break;}}else{const _0x1a5dd0=_0x14919b['target'][_0x422aaf(0x312)](_0x547455['iijkE']);if(_0x1a5dd0){if(_0x547455[_0x422aaf(0x25c)](_0x422aaf(0x303),_0x547455['guOYS']))_0x1719cf[_0x422aaf(0x143)](_0x547455[_0x422aaf(0x19f)]);else{const _0x22189b=_0x547455[_0x422aaf(0x2f0)](parseInt,_0x1a5dd0['getAttribute'](_0x422aaf(0xe2)));_0x547455[_0x422aaf(0x2f0)](selectOption,_0x22189b);}}}});}updateBookmarkButton(),_0x547455[_0x5b682a(0x1cf)](updateMarkReviewButton),(_0x547455[_0x5b682a(0x1ff)](currentMode,_0x547455['Jfnix'])||_0x547455[_0x5b682a(0xbe)](currentMode,_0x547455[_0x5b682a(0xf0)]))&&!isQuizCompleted&&startTimer();}function selectOption(_0x37f8b3){const _0x325178=_0x2a1f1a,_0x185c86={'KNpdL':_0x325178(0x118),'ZiPkf':function(_0x4f4847,_0x11c068){return _0x4f4847===_0x11c068;},'GRToc':'answered','LBJbM':_0x325178(0xc9),'DgRUK':_0x325178(0xc7),'OTkMN':function(_0x131b18,_0x2677bb){return _0x131b18===_0x2677bb;},'FGtWs':'timed_study','RLbtU':function(_0x4ae1bf,_0x4f9e26){return _0x4ae1bf!==_0x4f9e26;},'xNsMk':_0x325178(0x1cb),'cmCAC':function(_0x147104,_0x752a8a,_0x48b8e6){return _0x147104(_0x752a8a,_0x48b8e6);},'lOpZd':_0x325178(0x1a6),'McbCF':function(_0x4857fe){return _0x4857fe();}},_0x1ea891=document[_0x325178(0x284)](_0x325178(0x2b3));if(_0x1ea891[_0x325178(0x31f)][_0x325178(0x115)](_0x185c86[_0x325178(0x1df)]))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x325178(0x1d8)]+=Date['now']()-questionStartTime,questionStartTime=Date[_0x325178(0xfc)]()),selectedOption=_0x37f8b3,questionStates[currentQuestionIndex][_0x325178(0x222)]=_0x37f8b3,document[_0x325178(0x2f7)](_0x185c86[_0x325178(0x340)])[_0x325178(0x14b)]((_0x2a3f55,_0xba0fd1)=>{const _0x4f4a1b=_0x325178;_0x2a3f55['classList'][_0x4f4a1b(0x250)](_0x185c86[_0x4f4a1b(0x2ad)],_0x185c86[_0x4f4a1b(0x221)](_0xba0fd1,_0x37f8b3));}),currentMode===_0x185c86[_0x325178(0x100)]||_0x185c86[_0x325178(0x148)](currentMode,_0x185c86[_0x325178(0x167)])?_0x185c86[_0x325178(0x1d9)](_0x325178(0x28e),_0x185c86[_0x325178(0x214)])?_0x185c86[_0x325178(0xd8)](setTimeout,processAnswer,0x12c):_0x2cde22[_0x325178(0x325)]['forEach'](_0x1fe1c8=>{const _0x56f630=_0x325178;if(_0x1fe1c8)_0xe16f38+=_0x56f630(0x154)+_0x1fe1c8+_0x56f630(0x327);}):(_0x185c86['ZiPkf'](questionStates[currentQuestionIndex]['status'],_0x185c86[_0x325178(0xaf)])&&(questionStates[currentQuestionIndex][_0x325178(0xa0)]=_0x185c86[_0x325178(0x1df)],stats[_0x325178(0xd3)]++,stats[_0x325178(0x1e9)]--),_0x185c86['McbCF'](updateQuestionNav));}function processAnswer(){const _0x2f6f6a=_0x2a1f1a,_0xbc9808={'RhrHS':function(_0x4a227a,_0x1f2496){return _0x4a227a===_0x1f2496;},'RGksd':function(_0x22e777,_0x2c5e17){return _0x22e777===_0x2c5e17;},'mhzhF':_0x2f6f6a(0x1a6),'UBoSj':function(_0x46d32f,_0xa7a495){return _0x46d32f===_0xa7a495;},'iNAxZ':'TMSKc','VxgoF':_0x2f6f6a(0x102),'SEaND':_0x2f6f6a(0x288),'OOEDj':'incorrect','lOxqq':function(_0xa869aa){return _0xa869aa();},'ctuqC':function(_0x3e125b){return _0x3e125b();}},_0x2ede10=questionsData[currentQuestionIndex],_0x5c5fc5=_0x2ede10[_0x2f6f6a(0x224)];if(_0xbc9808[_0x2f6f6a(0x184)](selectedOption,null))return;const _0x2b4048=_0x2ede10[_0x2f6f6a(0xde)][selectedOption],_0xa2bdb3=_0x2b4048['id']===_0x5c5fc5;if(_0xbc9808['RGksd'](questionStates[currentQuestionIndex][_0x2f6f6a(0xa0)],_0xbc9808[_0x2f6f6a(0x10e)])){if(_0xbc9808[_0x2f6f6a(0x246)](_0xbc9808['iNAxZ'],_0xbc9808[_0x2f6f6a(0x31d)]))_0xcbc519();else{stats[_0x2f6f6a(0xd3)]++,stats[_0x2f6f6a(0x1e9)]--;if(_0xa2bdb3)stats[_0x2f6f6a(0x10c)]++;else stats[_0x2f6f6a(0x172)]++;}}questionStates[currentQuestionIndex]['status']=_0xa2bdb3?_0xbc9808[_0x2f6f6a(0xd2)]:_0xbc9808['OOEDj'],_0xbc9808[_0x2f6f6a(0x1bf)](updateStats),showInlineFeedback(_0xa2bdb3),_0xbc9808[_0x2f6f6a(0x2a2)](updateQuestionNav);}function showInlineFeedback(_0x1d7200){const _0x266e98=_0x2a1f1a,_0x1fe012={'iYopi':'selected','fXolt':_0x266e98(0x288),'VLeij':function(_0x20d28a,_0x3cf306){return _0x20d28a===_0x3cf306;},'qKQOH':_0x266e98(0x2da),'PRFqI':function(_0x19771d,_0x14dbab){return _0x19771d!==_0x14dbab;},'iiQUc':_0x266e98(0xc7),'dmcxE':'timed_study','BMRLJ':_0x266e98(0x2b3),'yuSOH':_0x266e98(0xc9),'cySmp':_0x266e98(0x1a3),'mkToX':function(_0x11dca4,_0x396654,_0x47a452){return _0x11dca4(_0x396654,_0x47a452);}};if(_0x1fe012['PRFqI'](currentMode,_0x1fe012['iiQUc'])&&currentMode!==_0x1fe012[_0x266e98(0x2d2)])return;const _0x16ecfb=document['getElementById'](_0x1fe012[_0x266e98(0x162)]),_0x8d5d00=_0x16ecfb[_0x266e98(0x2f7)](_0x1fe012[_0x266e98(0x1c2)]),_0x13c6e5=questionsData[currentQuestionIndex],_0x3a775e=_0x13c6e5[_0x266e98(0x224)];let _0x27c723=_0x13c6e5['choices'][_0x266e98(0x232)](_0x5301fc=>_0x5301fc['id']===_0x3a775e);_0x16ecfb[_0x266e98(0x31f)][_0x266e98(0x2ea)](_0x1fe012['cySmp']),_0x8d5d00[_0x266e98(0x14b)]((_0x27e65b,_0x545e40)=>{const _0x213208=_0x266e98;_0x27e65b[_0x213208(0x31f)][_0x213208(0xd7)](_0x1fe012[_0x213208(0x1c1)]);if(_0x545e40===_0x27c723)_0x27e65b[_0x213208(0x31f)]['add'](_0x1fe012['fXolt']);else{if(_0x1fe012['VLeij'](_0x545e40,selectedOption)&&!_0x1d7200)_0x27e65b[_0x213208(0x31f)][_0x213208(0x2ea)](_0x1fe012['qKQOH']);}}),_0x1fe012[_0x266e98(0x12f)](setTimeout,showSolution,0x5dc);}function showSolution(){const _0x4a37e2=_0x2a1f1a,_0x5ab716={'zeDbY':'answered','FZqzd':_0x4a37e2(0xa1),'Upqbh':function(_0x55c992,_0x5967c4){return _0x55c992===_0x5967c4;},'veZlB':'GizVQ','bJThf':_0x4a37e2(0x1f6),'EfcGu':function(_0x3df9b9,_0x242f9a){return _0x3df9b9!==_0x242f9a;},'IHVVd':_0x4a37e2(0xc7),'YSYxO':function(_0x9ebb40,_0x1ea632){return _0x9ebb40!==_0x1ea632;},'dsaTb':_0x4a37e2(0x280),'yGrYV':'solutionVideo','HZDmk':_0x4a37e2(0x1b5),'cwOzY':'lVNoL','YWucm':_0x4a37e2(0x1ed),'FNbRf':'.m3u8','CHrFU':'solutionAudio','KegVl':'WgFet','VHyaN':_0x4a37e2(0x2fa)};if(_0x5ab716[_0x4a37e2(0x180)](currentMode,_0x5ab716[_0x4a37e2(0x2dd)])&&_0x5ab716[_0x4a37e2(0xec)](currentMode,_0x4a37e2(0xe8)))return;const _0x114dde=questionsData[currentQuestionIndex];document[_0x4a37e2(0x284)](_0x4a37e2(0x26b))['innerHTML']=_0x114dde[_0x4a37e2(0x1bd)]||_0x5ab716[_0x4a37e2(0x265)];const _0x11c712=document[_0x4a37e2(0x284)](_0x5ab716['yGrYV']),_0x114336=document[_0x4a37e2(0x284)](_0x5ab716[_0x4a37e2(0xfe)]),_0x25a509=_0x114dde[_0x4a37e2(0x2d3)];if(_0x25a509){if(_0x5ab716[_0x4a37e2(0x160)]!==_0x5ab716[_0x4a37e2(0x160)])_0x295460[_0x4a37e2(0x320)]=_0x135e89;else{_0x11c712['classList'][_0x4a37e2(0xd7)](_0x5ab716[_0x4a37e2(0x28b)]);if(_0x25a509[_0x4a37e2(0x176)](_0x5ab716[_0x4a37e2(0x242)]))setupVideo(_0x114336,_0x25a509);else _0x114336[_0x4a37e2(0x320)]=_0x25a509;}}else _0x11c712[_0x4a37e2(0x31f)]['add'](_0x5ab716[_0x4a37e2(0x28b)]);const _0x3d1bbb=document[_0x4a37e2(0x284)](_0x5ab716[_0x4a37e2(0x2b9)]);_0x3d1bbb[_0x4a37e2(0x262)]='';_0x114dde['explanation_audio_eng']&&(_0x5ab716['KegVl']!==_0x5ab716['KegVl']?(_0x2359f6[_0x4e7899][_0x4a37e2(0xa0)]=_0x5ab716[_0x4a37e2(0x2e1)],_0x503674[_0x4a37e2(0xd3)]++,_0x1667ca['notAttempted']--):_0x3d1bbb[_0x4a37e2(0x262)]+=_0x4a37e2(0x1e8)+_0x114dde['explanation_audio_eng']+_0x4a37e2(0x21d));_0x114dde['explanation_audio_hin']&&(_0x3d1bbb[_0x4a37e2(0x262)]+=_0x4a37e2(0x198)+_0x114dde[_0x4a37e2(0x2b6)]+_0x4a37e2(0x21d));const _0x43b757=document[_0x4a37e2(0x284)](_0x4a37e2(0x1cd));_0x43b757['innerHTML']='',_0x114dde['explanation_images']&&_0x114dde[_0x4a37e2(0x323)][_0x4a37e2(0x14b)](_0x1ef359=>{const _0x3a8c64=_0x4a37e2;if(_0x5ab716['Upqbh'](_0x5ab716[_0x3a8c64(0x25e)],_0x5ab716['bJThf']))_0x3e1f3e[_0x3a8c64(0x284)](_0x3a8c64(0x2a9))['classList']['toggle'](_0x5ab716[_0x3a8c64(0x233)]);else{if(_0x1ef359)_0x43b757[_0x3a8c64(0x262)]+=_0x3a8c64(0x178)+_0x1ef359+_0x3a8c64(0x106);}}),document[_0x4a37e2(0x284)](_0x5ab716[_0x4a37e2(0x2a5)])['classList']['remove'](_0x5ab716[_0x4a37e2(0x28b)]);}function submitQuiz(){const _0x11c9a8=_0x2a1f1a,_0x2b6096={'oLMVM':_0x11c9a8(0x18e),'HpLcx':_0x11c9a8(0x281),'jesOL':_0x11c9a8(0x110),'ffpFK':_0x11c9a8(0xf4),'QZorG':function(_0x40037b,_0x629d7c){return _0x40037b!==_0x629d7c;},'KoCAH':_0x11c9a8(0x1f3),'efcpA':function(_0x7fda67,_0x2eb276){return _0x7fda67===_0x2eb276;},'nxrRr':_0x11c9a8(0x288),'WeJxu':_0x11c9a8(0x2da),'ZybLu':function(_0x2334a5,_0x1eaa27){return _0x2334a5(_0x1eaa27);},'GnHgs':'Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','NUBVP':function(_0x44b81d,_0xdc0289){return _0x44b81d-_0xdc0289;},'DGzAo':_0x11c9a8(0x105),'EGrXc':function(_0xbe8766,_0x19a1ee){return _0xbe8766+_0x19a1ee;},'bjuFh':function(_0x1048db,_0x3e6d6b,_0x183309,_0x463bdd,_0x596feb){return _0x1048db(_0x3e6d6b,_0x183309,_0x463bdd,_0x596feb);},'rkbgS':function(_0x2e8aa9,_0x5d3cf7){return _0x2e8aa9-_0x5d3cf7;}};if(timer)_0x2b6096[_0x11c9a8(0x1b7)](clearInterval,timer);if(!_0x2b6096[_0x11c9a8(0x1b7)](confirm,_0x2b6096[_0x11c9a8(0x1f8)]))return;isQuizCompleted=!![];let _0x17f60c=0x0,_0x45187e=0x0;const _0x534915=_0x2b6096[_0x11c9a8(0x331)](Date[_0x11c9a8(0xfc)](),quizStartTime);questionsData[_0x11c9a8(0x14b)]((_0x14737d,_0x1da823)=>{const _0x150a70=_0x11c9a8,_0x2bea11=questionStates[_0x1da823];if(_0x2b6096[_0x150a70(0x17d)](_0x2bea11[_0x150a70(0x222)],null)){if(_0x2b6096['QZorG'](_0x2b6096['KoCAH'],_0x150a70(0x1f3))){const _0x26c7d4=_0x1e4b58['getElementById'](_0x2b6096[_0x150a70(0x14a)]),_0xbf506b=_0x57a496[_0x150a70(0x284)](_0x150a70(0x33c)),_0x16c456=_0x1eb89e[_0x169ff4][_0x150a70(0x225)];_0x26c7d4[_0x150a70(0x298)]=_0x16c456?_0x150a70(0x241):_0x2b6096[_0x150a70(0x258)],_0xbf506b[_0x150a70(0x113)]=_0x16c456?_0x2b6096['jesOL']:_0x2b6096[_0x150a70(0x31b)];}else _0x2b6096[_0x150a70(0x33e)](_0x14737d[_0x150a70(0xde)][_0x2bea11[_0x150a70(0x222)]]['id'],_0x14737d[_0x150a70(0x224)])?(_0x17f60c++,_0x2bea11['status']=_0x2b6096[_0x150a70(0x2be)]):(_0x45187e++,_0x2bea11['status']=_0x2b6096['WeJxu']);}});const _0x5ea45a=JSON['parse'](localStorage[_0x11c9a8(0x1f9)](_0x2b6096['DGzAo']))||[];_0x5ea45a[_0x11c9a8(0x293)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date['now'](),'totalTime':_0x534915,'stats':{'correct':_0x17f60c,'incorrect':_0x45187e,'notAttempted':questionsData[_0x11c9a8(0x17f)]-_0x2b6096[_0x11c9a8(0x107)](_0x17f60c,_0x45187e)}}),localStorage[_0x11c9a8(0x32f)](_0x2b6096[_0x11c9a8(0x1b3)],JSON[_0x11c9a8(0x287)](_0x5ea45a)),_0x2b6096['bjuFh'](showPerformanceAnalysis,_0x17f60c,_0x45187e,_0x2b6096[_0x11c9a8(0x23c)](questionsData[_0x11c9a8(0x17f)],_0x17f60c+_0x45187e),_0x534915);}function showPerformanceAnalysis(_0x28c0e0,_0xc682e1,_0x384207,_0x428042){const _0x2e2a2a=_0x2a1f1a,_0x1460f4={'CDgvR':'performanceModal','DNlNm':function(_0x225daf,_0x29957c){return _0x225daf>_0x29957c;},'unsrZ':function(_0x51557e,_0x3f70cc){return _0x51557e+_0x3f70cc;},'TiGef':function(_0xdaaadf,_0x51e9bc){return _0xdaaadf*_0x51e9bc;},'zwpNj':function(_0x543d05,_0x250cd9){return _0x543d05*_0x250cd9;},'Lnsso':_0x2e2a2a(0x2ff),'xTRiH':function(_0x3bf90f,_0x520d61){return _0x3bf90f-_0x520d61;},'Onkzh':function(_0x4ed347,_0x8584cf){return _0x4ed347*_0x8584cf;},'kvnYj':function(_0xd8dcdb,_0x3cfcb6){return _0xd8dcdb/_0x3cfcb6;},'Ljzqx':_0x2e2a2a(0x150),'SrhQA':_0x2e2a2a(0x29e),'jRQLL':_0x2e2a2a(0x1bc),'XDCUm':_0x2e2a2a(0x271),'DNyrr':'notAttemptedResult','pMXus':function(_0x3205cb,_0x3d4a50){return _0x3205cb%_0x3d4a50;},'pfdnA':_0x2e2a2a(0x12d),'wZdhQ':'avgTimeResult'},_0x43164a=document[_0x2e2a2a(0x284)](_0x1460f4[_0x2e2a2a(0x15d)]),_0x499ba4=_0x1460f4[_0x2e2a2a(0x12e)](_0x1460f4[_0x2e2a2a(0x2a7)](_0x28c0e0,_0xc682e1),0x0)?Math[_0x2e2a2a(0x132)](_0x28c0e0/(_0x28c0e0+_0xc682e1)*0x64):0x0,_0x374625=_0x1460f4[_0x2e2a2a(0x194)](_0x1460f4[_0x2e2a2a(0x2b4)](0x2,Math['PI']),0x41),_0x2ee1e6=document[_0x2e2a2a(0x284)](_0x1460f4[_0x2e2a2a(0x229)]);_0x2ee1e6[_0x2e2a2a(0x2a1)][_0x2e2a2a(0x99)]=_0x374625+'\x20'+_0x374625,_0x2ee1e6[_0x2e2a2a(0x2a1)][_0x2e2a2a(0x1e6)]=_0x1460f4[_0x2e2a2a(0x1da)](_0x374625,_0x1460f4[_0x2e2a2a(0xbd)](_0x1460f4[_0x2e2a2a(0x15c)](_0x499ba4,0x64),_0x374625)),document[_0x2e2a2a(0x284)](_0x1460f4[_0x2e2a2a(0x2db)])['textContent']=_0x499ba4+'%',document[_0x2e2a2a(0x284)](_0x1460f4[_0x2e2a2a(0x2c4)])[_0x2e2a2a(0x113)]=questionsData[_0x2e2a2a(0x17f)],document[_0x2e2a2a(0x284)](_0x1460f4[_0x2e2a2a(0x157)])[_0x2e2a2a(0x113)]=_0x28c0e0,document[_0x2e2a2a(0x284)](_0x1460f4[_0x2e2a2a(0x1ba)])['textContent']=_0xc682e1,document[_0x2e2a2a(0x284)](_0x1460f4[_0x2e2a2a(0x2fd)])['textContent']=_0x384207;const _0x51d577=Math[_0x2e2a2a(0x138)](_0x428042/0xea60),_0x3bec39=Math['floor'](_0x1460f4[_0x2e2a2a(0x15c)](_0x1460f4[_0x2e2a2a(0x2f8)](_0x428042,0xea60),0x3e8));document[_0x2e2a2a(0x284)](_0x1460f4['pfdnA'])[_0x2e2a2a(0x113)]=_0x51d577+':'+_0x3bec39['toString']()[_0x2e2a2a(0x164)](0x2,'0');const _0x47caa9=_0x1460f4[_0x2e2a2a(0x15c)](_0x428042,questionsData[_0x2e2a2a(0x17f)]),_0x49c7b1=Math[_0x2e2a2a(0x138)](_0x47caa9/0xea60),_0x1152eb=Math['floor'](_0x1460f4[_0x2e2a2a(0x15c)](_0x47caa9%0xea60,0x3e8));document[_0x2e2a2a(0x284)](_0x1460f4[_0x2e2a2a(0x1d1)])[_0x2e2a2a(0x113)]=_0x49c7b1+':'+_0x1152eb['toString']()[_0x2e2a2a(0x164)](0x2,'0'),_0x43164a['classList']['remove'](_0x2e2a2a(0x1ed));}function closePerformanceModal(){const _0x3bceaf=_0x2a1f1a,_0x3590c4={'OWbhi':_0x3bceaf(0x1d3),'VzJsf':_0x3bceaf(0x1ed)};document['getElementById'](_0x3590c4['OWbhi'])[_0x3bceaf(0x31f)][_0x3bceaf(0x2ea)](_0x3590c4['VzJsf']);}function reviewQuestions(){const _0x2e16be=_0x2a1f1a,_0x410b63={'zwdFF':_0x2e16be(0x30e),'kUVeJ':'quizHierarchy','XWJsA':_0x2e16be(0x317),'wfUuC':function(_0x59a500,_0x36c12c){return _0x59a500===_0x36c12c;},'oWJmM':function(_0x1dee03,_0x2b1496){return _0x1dee03===_0x2b1496;},'dEsjN':_0x2e16be(0x291),'Rdbut':_0x2e16be(0x179),'gKSaC':_0x2e16be(0xa4),'Ojotv':function(_0x29700d,_0x2e3e5f){return _0x29700d+_0x2e3e5f;},'KSnJi':_0x2e16be(0xe1),'JbPdZ':_0x2e16be(0x15f),'KlDHC':function(_0xe0cd2e,_0x1f6525){return _0xe0cd2e===_0x1f6525;},'fdCug':_0x2e16be(0x2e6),'EMFQT':'correct','IoyYd':'incorrect','jjFHJ':'Incorrect','CJDZB':_0x2e16be(0x177),'rsFzX':_0x2e16be(0xb0),'nHYCl':_0x2e16be(0x147),'NUhOU':_0x2e16be(0x19b),'bFuIm':'questionReviewSection','cRVuj':'hidden','LNEaj':_0x2e16be(0x145),'RcWzh':function(_0x11b320){return _0x11b320();}};document['getElementById'](_0x410b63['bFuIm'])[_0x2e16be(0x31f)][_0x2e16be(0xd7)](_0x410b63[_0x2e16be(0x28c)]);const _0x4bd676=document[_0x2e16be(0x284)](_0x410b63[_0x2e16be(0x226)]);_0x4bd676[_0x2e16be(0x262)]='',questionsData[_0x2e16be(0x14b)]((_0x2200ba,_0x2c202a)=>{const _0x5cda3=_0x2e16be,_0x313378=questionStates[_0x2c202a],_0x27e45e=_0x2200ba['correct_choice_id'];let _0x53acfb=_0x410b63['KSnJi'],_0x499e10=_0x410b63['JbPdZ'];if(_0x313378['selectedAnswer']!==null){if(_0x410b63[_0x5cda3(0x204)](_0x410b63[_0x5cda3(0x24b)],_0x410b63[_0x5cda3(0x24b)])){const _0x24cb54=_0x2200ba[_0x5cda3(0xde)][_0x313378['selectedAnswer']];_0x24cb54['id']===_0x27e45e?(_0x53acfb=_0x410b63[_0x5cda3(0x339)],_0x499e10='Correct'):(_0x53acfb=_0x410b63['IoyYd'],_0x499e10=_0x410b63[_0x5cda3(0x19c)]);}else{const _0x3b2fda=_0x1264da[_0x5cda3(0x27f)](_0x3c8dd3[_0x5cda3(0x1f9)](_0x5cda3(0x24e)));if(_0x3b2fda){const _0x325b73=_0x5cda3(0x2f5)[_0x5cda3(0x2f1)]('|');let _0x3bd7d8=0x0;while(!![]){switch(_0x325b73[_0x3bd7d8++]){case'0':_0x2e51e7[_0x5cda3(0x284)](_0x410b63[_0x5cda3(0x2cb)])[_0x5cda3(0x113)]=_0x237220[_0x5cda3(0x17f)];continue;case'1':_0x1aecb8=_0x3b2fda[_0x5cda3(0x142)];continue;case'2':_0x4886f3[_0x5cda3(0x284)](_0x410b63[_0x5cda3(0x1f1)])[_0x5cda3(0x113)]=_0xfafdce[_0x5cda3(0x2e9)](_0x410b63[_0x5cda3(0x21c)]);continue;case'3':_0x7a720d=_0x3b2fda[_0x5cda3(0x2ae)];continue;case'4':_0x5197fd[_0x5cda3(0x245)]=_0x3425c0+_0x5cda3(0x22e);continue;case'5':_0xccc248=_0x3b2fda[_0x5cda3(0x1c7)];continue;}break;}}}}const _0x45da6a=document['createElement'](_0x410b63[_0x5cda3(0x13f)]);_0x45da6a[_0x5cda3(0x298)]='review-question\x20'+_0x53acfb;let _0x428af3=(_0x2200ba['choices']||[])[_0x5cda3(0x2fe)]((_0x4726d1,_0x5c80ea)=>{const _0x33dd5a=_0x5cda3;if(_0x410b63[_0x33dd5a(0x16b)](_0x33dd5a(0x9f),_0x33dd5a(0x9f))){const _0x52fe4f=_0x410b63[_0x33dd5a(0x244)](_0x313378[_0x33dd5a(0x222)],_0x5c80ea),_0x46faa8=_0x410b63[_0x33dd5a(0x16b)](_0x4726d1['id'],_0x27e45e);let _0xb25cae=_0x410b63[_0x33dd5a(0xf5)];if(_0x46faa8)_0xb25cae=_0x410b63[_0x33dd5a(0x266)];else{if(_0x52fe4f)_0xb25cae=_0x410b63[_0x33dd5a(0x1e7)];}return _0x33dd5a(0x133)+_0xb25cae+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+String['fromCharCode'](_0x410b63[_0x33dd5a(0xf2)](0x41,_0x5c80ea))+_0x33dd5a(0x1b0)+_0x4726d1['text']+_0x33dd5a(0x1c0);}else{const _0x1c8c6c=_0x271415?function(){const _0x1c9553=_0x33dd5a;if(_0xf84556){const _0x479e86=_0x557fb4[_0x1c9553(0x223)](_0x395070,arguments);return _0x2d3cb5=null,_0x479e86;}}:function(){};return _0x2c47ef=![],_0x1c8c6c;}})['join']('');const _0x4a8ba3=_0x2200ba['explanation_video']?_0x5cda3(0x27e)+_0x2c202a+_0x5cda3(0x218)+_0x2200ba[_0x5cda3(0x2d3)]+'\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>':'';let _0x456482='';if(_0x2200ba[_0x5cda3(0x199)])_0x456482+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22'+_0x2200ba[_0x5cda3(0x199)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';if(_0x2200ba[_0x5cda3(0x2b6)])_0x456482+=_0x5cda3(0x1ce)+_0x2200ba[_0x5cda3(0x2b6)]+_0x5cda3(0x21d);let _0xbe3548=(_0x2200ba[_0x5cda3(0x323)]||[])[_0x5cda3(0x2fe)](_0x21ee7d=>_0x21ee7d?_0x5cda3(0x178)+_0x21ee7d+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>':'')['join']('');_0x45da6a[_0x5cda3(0x262)]=_0x5cda3(0xaa)+(_0x2c202a+0x1)+'</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-'+(_0x410b63[_0x5cda3(0x244)](_0x53acfb,_0x410b63['EMFQT'])?_0x410b63[_0x5cda3(0x131)]:_0x410b63[_0x5cda3(0x204)](_0x53acfb,_0x410b63[_0x5cda3(0x32e)])?_0x410b63[_0x5cda3(0x114)]:_0x5cda3(0xee))+'-600\x20text-white\x22>'+_0x499e10+_0x5cda3(0x1a7)+_0x2200ba[_0x5cda3(0x125)]+_0x5cda3(0x1f2)+_0x428af3+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>'+(_0x2200ba[_0x5cda3(0x1bd)]||_0x410b63[_0x5cda3(0x236)])+_0x5cda3(0x19a)+_0x4a8ba3+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x456482+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0xbe3548+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x4bd676[_0x5cda3(0x272)](_0x45da6a);}),_0x410b63[_0x2e16be(0x2a8)](initializeReviewVideos);}function initializeReviewVideos(){const _0x13f17d=_0x2a1f1a,_0x33205e={'RIZLN':function(_0x4c1fdb){return _0x4c1fdb();},'ezcDr':function(_0x39b15e,_0x25861e){return _0x39b15e===_0x25861e;},'TXaJC':'CWpkF','KzCHc':function(_0x1e87a1,_0x39b59d,_0x57fba2){return _0x1e87a1(_0x39b59d,_0x57fba2);},'oygXV':_0x13f17d(0x1a5)};document[_0x13f17d(0x2f7)](_0x33205e[_0x13f17d(0x26a)])['forEach'](_0x223406=>{const _0x359919=_0x13f17d;if(_0x33205e[_0x359919(0x29b)](_0x33205e[_0x359919(0x200)],_0x33205e[_0x359919(0x200)])){const _0x2f45a7=_0x223406[_0x359919(0x2ba)][_0x359919(0x320)];if(_0x2f45a7&&_0x2f45a7['includes'](_0x359919(0xa9)))_0x33205e['KzCHc'](setupVideo,_0x223406,_0x2f45a7);else _0x2f45a7&&(_0x223406[_0x359919(0x320)]=_0x2f45a7);}else _0x2edbc7[_0x359919(0x22b)](),_0x33205e[_0x359919(0x33b)](_0x58c140);});}function retakeQuiz(){const _0x3823b1=_0x2a1f1a,_0x4a76ca={'PIKPd':function(_0x40b380,_0x571680){return _0x40b380(_0x571680);},'yCOmL':_0x3823b1(0xe7),'AeWxQ':_0x3823b1(0x24e)};_0x4a76ca[_0x3823b1(0x11d)](confirm,_0x3823b1(0x111))&&(window[_0x3823b1(0xdd)][_0x3823b1(0x2aa)][_0x3823b1(0x30f)](_0x4a76ca[_0x3823b1(0x2c5)])&&localStorage[_0x3823b1(0x143)](_0x4a76ca[_0x3823b1(0x104)]),location[_0x3823b1(0x2e2)]());}function loadBookmarkedQuestions(){const _0x264489=_0x2a1f1a,_0x583132={'MBmKT':_0x264489(0x122),'hxXvY':'Correct','fdhud':_0x264489(0x2da),'SuImc':function(_0x7904ab,_0x59b6eb){return _0x7904ab===_0x59b6eb;},'kOZMT':'FvWiz','SSFwq':function(_0x60d695,_0x1c7e99){return _0x60d695<_0x1c7e99;},'GuhUR':function(_0x439b1f,_0x4c7e9e){return _0x439b1f!==_0x4c7e9e;},'reIuM':_0x264489(0x276)},_0x57ee34=JSON[_0x264489(0x27f)](localStorage['getItem'](_0x264489(0x32c)))||[];_0x57ee34[_0x264489(0x14b)](_0x359041=>{const _0x162098=_0x264489,_0x4d24e9={'vjeNu':function(_0x24582d,_0x43937d){return _0x24582d===_0x43937d;},'AyZPP':_0x162098(0x288),'SLwle':_0x583132[_0x162098(0x2cd)],'OsTCm':_0x583132['fdhud']};if(_0x583132[_0x162098(0x1ec)](_0x583132[_0x162098(0x16c)],_0x583132[_0x162098(0x16c)])){if(_0x359041[_0x162098(0x228)][_0x162098(0x176)](quizName[_0x162098(0x33a)]()['replace'](/ /g,'-'))){if(_0x583132['SSFwq'](_0x359041[_0x162098(0x1f7)],questionsData[_0x162098(0x17f)])){if(_0x583132['GuhUR'](_0x162098(0x21b),_0x583132['reIuM']))questionStates[_0x359041[_0x162098(0x1f7)]][_0x162098(0x1c3)]=!![];else{const _0x3ba483=_0x26f324[_0x162098(0xde)][_0x267bc0['selectedAnswer']];_0x4d24e9[_0x162098(0x1fd)](_0x3ba483['id'],_0x4b06f1)?(_0x176b00=_0x4d24e9['AyZPP'],_0x58db2a=_0x4d24e9[_0x162098(0xc8)]):(_0x2a3687=_0x4d24e9[_0x162098(0x29d)],_0x2bc05e=_0x162098(0x326));}}}}else(_0x37dbc5||_0x4cbf38(_0x583132['MBmKT']))&&_0xfe587d[_0x162098(0x237)][_0x162098(0x10d)]();});}function toggleBookmark(){const _0xd0a122=_0x2a1f1a,_0x56e3f2={'GXAhT':_0xd0a122(0x32c),'nRnpD':function(_0x35ea22){return _0x35ea22();}},_0x3b52d0=!questionStates[currentQuestionIndex]['bookmarked'];questionStates[currentQuestionIndex]['bookmarked']=_0x3b52d0;let _0x1358e0=JSON[_0xd0a122(0x27f)](localStorage[_0xd0a122(0x1f9)]('bookmarkedQuestions'))||[];if(_0x3b52d0){const _0x2dd3cf={'quizName':quizName,'quizFile':window[_0xd0a122(0xdd)][_0xd0a122(0x2aa)][_0xd0a122(0x2f1)]('/')['pop'](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0xd0a122(0xfc)]()};_0x1358e0['push'](_0x2dd3cf);}else _0x1358e0=_0x1358e0[_0xd0a122(0x2e0)](_0x4a8888=>!(_0x4a8888['quizFile'][_0xd0a122(0x176)](quizName[_0xd0a122(0x33a)]()['replace'](/ /g,'-'))&&_0x4a8888['questionIndex']===currentQuestionIndex));localStorage[_0xd0a122(0x32f)](_0x56e3f2[_0xd0a122(0x151)],JSON[_0xd0a122(0x287)](_0x1358e0)),updateBookmarkButton(),_0x56e3f2[_0xd0a122(0x219)](updateQuestionNav);}function updateBookmarkButton(){const _0xcbb7df=_0x2a1f1a,_0xeac55a={'QStGo':_0xcbb7df(0x263),'nOOfX':_0xcbb7df(0x2e4),'rdQBE':_0xcbb7df(0x1d0),'iexmG':'Bookmarked','iAieK':_0xcbb7df(0x1f5)},_0x251a03=document[_0xcbb7df(0x284)](_0xcbb7df(0x2ed)),_0x3fa14e=document[_0xcbb7df(0x284)](_0xeac55a[_0xcbb7df(0x1ad)]),_0x6c49f=questionStates[currentQuestionIndex][_0xcbb7df(0x1c3)];_0x251a03[_0xcbb7df(0x298)]=_0x6c49f?_0xeac55a[_0xcbb7df(0x24c)]:_0xeac55a['rdQBE'],_0x3fa14e[_0xcbb7df(0x113)]=_0x6c49f?_0xeac55a[_0xcbb7df(0x2a0)]:_0xeac55a['iAieK'];}function toggleMarkForReview(){const _0x1d30ee={'kiBMF':function(_0xf0256a){return _0xf0256a();}};questionStates[currentQuestionIndex]['markedForReview']=!questionStates[currentQuestionIndex]['markedForReview'],_0x1d30ee['kiBMF'](updateMarkReviewButton),updateQuestionNav();}function updateMarkReviewButton(){const _0x407511=_0x2a1f1a,_0x54641d={'jopwC':_0x407511(0x33c),'OJUoM':_0x407511(0x241),'jhQkR':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','sPMfc':_0x407511(0x110),'iZEyt':_0x407511(0xf4)},_0x10d1bd=document[_0x407511(0x284)](_0x407511(0x18e)),_0x46c850=document[_0x407511(0x284)](_0x54641d[_0x407511(0x255)]),_0x5629eb=questionStates[currentQuestionIndex][_0x407511(0x225)];_0x10d1bd[_0x407511(0x298)]=_0x5629eb?_0x54641d[_0x407511(0x155)]:_0x54641d[_0x407511(0x2c6)],_0x46c850[_0x407511(0x113)]=_0x5629eb?_0x54641d[_0x407511(0x1de)]:_0x54641d[_0x407511(0x20f)];}function previousQuestion(){const _0x1fcaaf=_0x2a1f1a,_0x7eee0b={'WEDGX':'nav-btn-bookmarked','hqfqE':function(_0x27a85e,_0x46fda4){return _0x27a85e>_0x46fda4;},'Rjixz':function(_0x50063f,_0x233117){return _0x50063f===_0x233117;},'HMmla':_0x1fcaaf(0x341),'SmClC':'UTAzC','qiTVG':function(_0x525e38,_0x101c3b){return _0x525e38-_0x101c3b;},'RoNdA':function(_0x25296e){return _0x25296e();}};_0x7eee0b[_0x1fcaaf(0x304)](currentQuestionIndex,0x0)&&(_0x7eee0b[_0x1fcaaf(0x314)](_0x7eee0b[_0x1fcaaf(0x286)],_0x7eee0b[_0x1fcaaf(0x286)])?(questionStartTime&&(_0x7eee0b[_0x1fcaaf(0x314)](_0x7eee0b['SmClC'],_0x1fcaaf(0x33f))?_0x4e42bb=_0x7eee0b['WEDGX']:questionStates[currentQuestionIndex][_0x1fcaaf(0x1d8)]+=_0x7eee0b[_0x1fcaaf(0x24f)](Date['now'](),questionStartTime)),currentQuestionIndex--,_0x7eee0b['RoNdA'](displayQuestion)):_0x4a3115['history'][_0x1fcaaf(0x10d)]());}function nextQuestion(){const _0x346dd1=_0x2a1f1a,_0x4128a2={'YlZXf':_0x346dd1(0x288),'nJXQp':_0x346dd1(0xf1),'HOAVM':'incorrect','uEXPE':_0x346dd1(0xe6),'RcCqb':function(_0x1d7b55,_0x580436){return _0x1d7b55===_0x580436;},'ozUaZ':'study','dIpIi':function(_0x27dbd2,_0x262108){return _0x27dbd2!==_0x262108;},'qrtln':'timed_study','PtlBs':_0x346dd1(0x2b3),'srpml':_0x346dd1(0x1a3),'egqqT':function(_0x6b0e75,_0x700276,_0x2f5f8d){return _0x6b0e75(_0x700276,_0x2f5f8d);},'haczL':function(_0x4d7a4d){return _0x4d7a4d();},'olngU':_0x346dd1(0xdc),'NWZlI':function(_0x4b5413,_0x42b8b6){return _0x4b5413<_0x42b8b6;},'UKrMI':'aZJiH','flRup':_0x346dd1(0x18f),'uKZvR':function(_0x34b5e8,_0x5bcdfb){return _0x34b5e8===_0x5bcdfb;},'esDBQ':function(_0x3b7d2c){return _0x3b7d2c();},'ucPKd':function(_0x3baa95,_0x7d70da){return _0x3baa95(_0x7d70da);},'RFMxL':_0x346dd1(0xfb),'htxbb':_0x346dd1(0x15a)};if(questionStartTime){if(_0x4128a2['dIpIi'](_0x4128a2[_0x346dd1(0x123)],_0x346dd1(0x2cc)))questionStates[currentQuestionIndex][_0x346dd1(0x1d8)]+=Date[_0x346dd1(0xfc)]()-questionStartTime;else{if(_0xbc2012[_0x346dd1(0xa0)]===_0x4128a2[_0x346dd1(0x13c)])_0x2f535a=_0x4128a2['nJXQp'];else{if(_0x3bae86[_0x346dd1(0xa0)]===_0x4128a2['HOAVM'])_0x4cef1f=_0x346dd1(0x330);else _0x414686=_0x4128a2['uEXPE'];}}}if(_0x4128a2[_0x346dd1(0x30c)](currentQuestionIndex,questionsData[_0x346dd1(0x17f)]-0x1))currentQuestionIndex++,_0x4128a2['haczL'](displayQuestion);else{if(_0x4128a2[_0x346dd1(0x334)](_0x4128a2[_0x346dd1(0x313)],_0x4128a2[_0x346dd1(0x1e4)])){const _0x1445da={'PbhVz':function(_0x1b23c0,_0x231271){const _0x2c2e39=_0x346dd1;return _0x4128a2[_0x2c2e39(0x334)](_0x1b23c0,_0x231271);},'wNIPP':_0x4128a2[_0x346dd1(0x13c)],'vCndq':function(_0xad3327,_0x282ac6){return _0xad3327===_0x282ac6;}};if(_0x5088b0!==_0x4128a2[_0x346dd1(0xb9)]&&_0x4128a2['dIpIi'](_0x4c227f,_0x4128a2['qrtln']))return;const _0x438929=_0x49e782[_0x346dd1(0x284)](_0x4128a2[_0x346dd1(0x9a)]),_0x58c404=_0x438929[_0x346dd1(0x2f7)]('.option-button'),_0x4041db=_0xb751bb[_0x359d2d],_0x4467a8=_0x4041db[_0x346dd1(0x224)];let _0x5b4879=_0x4041db[_0x346dd1(0xde)]['findIndex'](_0x161e73=>_0x161e73['id']===_0x4467a8);_0x438929[_0x346dd1(0x31f)][_0x346dd1(0x2ea)](_0x4128a2[_0x346dd1(0x9b)]),_0x58c404[_0x346dd1(0x14b)]((_0x49c44b,_0x176f44)=>{const _0x20cf21=_0x346dd1;_0x49c44b[_0x20cf21(0x31f)][_0x20cf21(0xd7)](_0x20cf21(0x118));if(_0x1445da[_0x20cf21(0x2e7)](_0x176f44,_0x5b4879))_0x49c44b['classList']['add'](_0x1445da[_0x20cf21(0x2ef)]);else{if(_0x1445da[_0x20cf21(0x1d6)](_0x176f44,_0x2eda39)&&!_0x5473e9)_0x49c44b[_0x20cf21(0x31f)][_0x20cf21(0x2ea)](_0x20cf21(0x2da));}}),_0x4128a2[_0x346dd1(0x185)](_0x3ea50a,_0x1fd431,0x5dc);}else _0x4128a2['RcCqb'](currentMode,_0x346dd1(0x1ee))||_0x4128a2['uKZvR'](currentMode,_0x346dd1(0x163))?confirm(_0x346dd1(0x2ec))&&_0x4128a2['esDBQ'](submitQuiz):_0x4128a2[_0x346dd1(0x1af)](confirm,_0x4128a2['RFMxL'])&&(_0x4128a2[_0x346dd1(0x1b8)](_0x4128a2[_0x346dd1(0x1d2)],_0x4128a2[_0x346dd1(0x1d2)])?(currentQuestionIndex=0x0,displayQuestion()):_0x4128a2[_0x346dd1(0x2c0)](_0xa392a6));}}function startTimer(){const _0x490418=_0x2a1f1a,_0x23b935={'UxfOz':function(_0x5062c1,_0x37ba2b){return _0x5062c1(_0x37ba2b);},'oHKsD':function(_0x1fb123){return _0x1fb123();},'Jworc':_0x490418(0xbf),'IcrBv':function(_0x3f1c0c){return _0x3f1c0c();},'RvROU':function(_0x504890,_0x5b9688){return _0x504890===_0x5b9688;},'CcImh':_0x490418(0x163),'iGbAh':function(_0x3ae759,_0x4aba5c){return _0x3ae759===_0x4aba5c;},'xDZGH':_0x490418(0x1eb),'HEmbT':_0x490418(0x9c),'Unguv':function(_0xd48a56,_0x187039){return _0xd48a56(_0x187039);},'dkiTq':function(_0x5ec286,_0x1b3202,_0x2d1cdc){return _0x5ec286(_0x1b3202,_0x2d1cdc);}};if(timer)_0x23b935[_0x490418(0x208)](clearInterval,timer);timeRemaining=0x78,_0x23b935['oHKsD'](updateTimerDisplay),timer=_0x23b935[_0x490418(0x1c6)](setInterval,()=>{const _0x14f625=_0x490418,_0x366b90={'oPAJR':function(_0x354875,_0x53c482){const _0x183462=_0x3fb3;return _0x23b935[_0x183462(0x2b5)](_0x354875,_0x53c482);},'glhkX':function(_0x501374,_0x61a4ae){return _0x501374===_0x61a4ae;},'FPMMv':'timed_exam','oIYdy':function(_0x1f5f1c){const _0x2a7aa2=_0x3fb3;return _0x23b935[_0x2a7aa2(0x247)](_0x1f5f1c);},'shWGm':_0x23b935[_0x14f625(0xa6)]};timeRemaining--,_0x23b935['IcrBv'](updateTimerDisplay),timeRemaining<=0x0&&(clearInterval(timer),_0x23b935['RvROU'](currentMode,_0x23b935[_0x14f625(0x12b)])?_0x23b935[_0x14f625(0x310)](_0x23b935[_0x14f625(0x300)],_0x14f625(0x1eb))?submitQuiz():(_0x366b90['oPAJR'](_0x33caa9,_0xb0270a),_0x366b90[_0x14f625(0xd4)](_0x293fb9,_0x366b90['FPMMv'])?_0x366b90[_0x14f625(0x17a)](_0x2cfb73):_0x366b90[_0x14f625(0x17a)](_0xfeb918)):_0x23b935['HEmbT']===_0x23b935[_0x14f625(0x230)]?_0x23b935['IcrBv'](nextQuestion):_0xfd8f43=_0x366b90[_0x14f625(0xdf)]);},0x3e8);}function updateTimerDisplay(){const _0x206007=_0x2a1f1a,_0x49f554={'byeSY':function(_0x186caa,_0x4b7333){return _0x186caa/_0x4b7333;},'UGdoD':function(_0x3cf1b0,_0x34b195){return _0x3cf1b0%_0x34b195;},'ZaidN':function(_0x53d9fa,_0x209881){return _0x53d9fa+_0x209881;}},_0x49ebdc=Math['floor'](_0x49f554[_0x206007(0x315)](timeRemaining,0x3c)),_0x46b2f5=_0x49f554['UGdoD'](timeRemaining,0x3c);document[_0x206007(0x284)](_0x206007(0x108))['textContent']=_0x49f554[_0x206007(0x30b)](_0x49ebdc,':')+_0x46b2f5[_0x206007(0x2f6)]()[_0x206007(0x164)](0x2,'0');}function toggleSidebar(){const _0x4b1a7f=_0x2a1f1a,_0x486489={'xKgJC':'open'};document[_0x4b1a7f(0x284)]('quizSidebar')['classList'][_0x4b1a7f(0x250)](_0x486489[_0x4b1a7f(0x299)]);}document[_0x2a1f1a(0x289)](_0x2a1f1a(0x10b),()=>{const _0x471c4e=_0x2a1f1a,_0x3015e7={'mzcmt':function(_0xf1d385){return _0xf1d385();},'dyPTU':_0x471c4e(0x1a6),'BVNBj':'answered','rPbNX':function(_0x120e59){return _0x120e59();},'wuOOL':_0x471c4e(0xe7),'BITyn':function(_0x24d327,_0x1ff9ab){return _0x24d327!==_0x1ff9ab;},'ClRkj':_0x471c4e(0x182),'Xwhgh':'modeModal','kqLWj':_0x471c4e(0x186),'YDghv':_0x471c4e(0x2e3)};!window['location'][_0x471c4e(0x2aa)][_0x471c4e(0x30f)](_0x3015e7[_0x471c4e(0x212)])?_0x3015e7['BITyn'](_0x3015e7['ClRkj'],_0x3015e7[_0x471c4e(0x254)])?_0x3015e7[_0x471c4e(0x268)](_0x10c7a1):document[_0x471c4e(0x284)](_0x3015e7[_0x471c4e(0x253)])[_0x471c4e(0x2a1)][_0x471c4e(0x2b1)]=_0x3015e7[_0x471c4e(0x278)]:_0x3015e7[_0x471c4e(0x234)](_0x3015e7[_0x471c4e(0xa5)],_0x3015e7[_0x471c4e(0xa5)])?(_0x3e7952[_0x58771d][_0x471c4e(0xa0)]===_0x3015e7[_0x471c4e(0x25d)]&&(_0x48fd76[_0x232e4c][_0x471c4e(0xa0)]=_0x3015e7['BVNBj'],_0x4945b3['totalAttempted']++,_0x504aea[_0x471c4e(0x1e9)]--),_0x3015e7['rPbNX'](_0x4d9c9c)):_0x3015e7[_0x471c4e(0x268)](initializeQuiz);}),document[_0x2a1f1a(0x289)]('keydown',function(_0x346eba){const _0x58a00d=_0x2a1f1a,_0x187bc1={'WtIzJ':function(_0x5fdf0d,_0x4c984e){return _0x5fdf0d<_0x4c984e;},'LteBI':_0x58a00d(0x32c),'NGifK':function(_0x3bed14){return _0x3bed14();},'tlrCG':function(_0x280b31){return _0x280b31();},'kIITn':_0x58a00d(0x256),'qosZf':function(_0xf885dd,_0xc18271){return _0xf885dd===_0xc18271;},'gJYNo':'performanceModal','nbCBA':'hidden','phNcf':function(_0x459fb6,_0x3f8441){return _0x459fb6>=_0x3f8441;},'pRhdR':function(_0x1733ed,_0x34585c){return _0x1733ed<=_0x34585c;},'kUrCI':function(_0x302360,_0x208d75){return _0x302360(_0x208d75);},'sZeHf':'.option-button','jNHQx':_0x58a00d(0x23b),'XnxZv':_0x58a00d(0x332),'OBJPu':function(_0x3a283f,_0xca4217){return _0x3a283f===_0xca4217;},'qhLsQ':function(_0x1f51ea,_0x2e9820){return _0x1f51ea!==_0x2e9820;},'IWNNK':_0x58a00d(0x16e),'HhVXs':function(_0x301cb0){return _0x301cb0();},'yeAfF':_0x58a00d(0xc7),'ZrrEA':function(_0x559b0d,_0x5cc722){return _0x559b0d===_0x5cc722;},'HCmDe':'timed_study','lnjje':function(_0x3a0aff){return _0x3a0aff();},'thcwA':function(_0x16e794,_0x6301c2){return _0x16e794===_0x6301c2;},'xgcRD':_0x58a00d(0x163),'kQuFw':function(_0x19178a,_0x2deaec){return _0x19178a===_0x2deaec;},'iqgiA':function(_0x9e3b48,_0x4b78c3){return _0x9e3b48===_0x4b78c3;}};if(document['getElementById'](_0x58a00d(0x1fa))[_0x58a00d(0x2a1)][_0x58a00d(0x2b1)]!==_0x187bc1['kIITn'])return;if(_0x187bc1[_0x58a00d(0x2de)](document[_0x58a00d(0x284)](_0x187bc1[_0x58a00d(0x11e)])[_0x58a00d(0x31f)][_0x58a00d(0x115)](_0x187bc1[_0x58a00d(0x1be)]),![]))return;if(_0x187bc1[_0x58a00d(0x165)](_0x346eba['key'],'1')&&_0x187bc1[_0x58a00d(0x235)](_0x346eba[_0x58a00d(0xd9)],'4')){const _0x276b39=_0x187bc1[_0x58a00d(0x1c5)](parseInt,_0x346eba[_0x58a00d(0xd9)])-0x1,_0x1cd2e7=document[_0x58a00d(0x2f7)](_0x187bc1[_0x58a00d(0xa8)]);if(_0x187bc1[_0x58a00d(0x202)](_0x276b39,_0x1cd2e7[_0x58a00d(0x17f)]))selectOption(_0x276b39);}else{if(_0x346eba[_0x58a00d(0xd9)]===_0x187bc1[_0x58a00d(0x1c8)])_0x187bc1[_0x58a00d(0x2de)](_0x187bc1[_0x58a00d(0xb7)],_0x187bc1[_0x58a00d(0xb7)])?previousQuestion():_0x4a2a71['quizFile']['includes'](_0x474d93[_0x58a00d(0x33a)]()[_0x58a00d(0x307)](/ /g,'-'))&&(_0x187bc1[_0x58a00d(0x202)](_0x1df596[_0x58a00d(0x1f7)],_0x24e7bc[_0x58a00d(0x17f)])&&(_0x15ec31[_0x4604bb[_0x58a00d(0x1f7)]][_0x58a00d(0x1c3)]=!![]));else{if(_0x187bc1[_0x58a00d(0x2de)](_0x346eba['key'],_0x58a00d(0x101))||_0x187bc1[_0x58a00d(0x205)](_0x346eba[_0x58a00d(0xd9)],'\x20')){if(_0x187bc1[_0x58a00d(0x153)](_0x187bc1['IWNNK'],_0x187bc1[_0x58a00d(0x335)])){const _0x422fce=!_0x53cd9b[_0x4679f5][_0x58a00d(0x1c3)];_0x1d7ffb[_0x35d3a7][_0x58a00d(0x1c3)]=_0x422fce;let _0x39b62d=_0x5d3f92[_0x58a00d(0x27f)](_0xb5b99b['getItem'](_0x187bc1[_0x58a00d(0xcd)]))||[];if(_0x422fce){const _0x4df9f4={'quizName':_0x1c545c,'quizFile':_0x5a5b08[_0x58a00d(0xdd)][_0x58a00d(0x2aa)][_0x58a00d(0x2f1)]('/')[_0x58a00d(0x31e)](),'questionIndex':_0x52fcf0,'question':_0x214f3f[_0xaef209],'hierarchy':_0x514bc0,'timestamp':_0x4a7980[_0x58a00d(0xfc)]()};_0x39b62d[_0x58a00d(0x293)](_0x4df9f4);}else _0x39b62d=_0x39b62d[_0x58a00d(0x2e0)](_0x39c70c=>!(_0x39c70c[_0x58a00d(0x228)][_0x58a00d(0x176)](_0x5e14b1['toLowerCase']()['replace'](/ /g,'-'))&&_0x39c70c[_0x58a00d(0x1f7)]===_0x18de79));_0x533818[_0x58a00d(0x32f)](_0x187bc1[_0x58a00d(0xcd)],_0x3f9414[_0x58a00d(0x287)](_0x39b62d)),_0x187bc1[_0x58a00d(0x124)](_0x3a9a4b),_0x187bc1['tlrCG'](_0x18c4c1);}else _0x346eba[_0x58a00d(0x22b)](),_0x187bc1['HhVXs'](nextQuestion);}else{if(_0x346eba[_0x58a00d(0xd9)][_0x58a00d(0x33a)]()==='b'&&(currentMode===_0x187bc1['yeAfF']||_0x187bc1[_0x58a00d(0x20b)](currentMode,_0x187bc1[_0x58a00d(0x294)])))_0x187bc1['lnjje'](toggleBookmark);else{if(_0x346eba[_0x58a00d(0xd9)][_0x58a00d(0x33a)]()==='m'&&(currentMode==='test'||_0x187bc1[_0x58a00d(0x152)](currentMode,_0x187bc1[_0x58a00d(0x140)])))_0x187bc1[_0x58a00d(0x23d)](toggleMarkForReview);else _0x187bc1[_0x58a00d(0x112)](_0x346eba[_0x58a00d(0xd9)]['toLowerCase'](),'s')&&(currentMode===_0x58a00d(0x1ee)||_0x187bc1['iqgiA'](currentMode,_0x187bc1[_0x58a00d(0x140)]))&&submitQuiz();}}}}});</script>

</body></html>